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CHAPTER I 
INTRODUCTION 
A. General 
Post-streptococcal glomerulonephritis, along with 
several other glomerulonephritides, is an inflammatory 
disease involving the renal glomerulus .. Chiefly involving 
children and young adults, it is characterized by hema-
turia, edema and hypertension. Although complete recovery 
is the rule, on occasion the disease may become chronic 
(5) and even fatal. 
The relationship between scarlet fever and renal 
disease was noted as early as the 17th century, although it 
was not emphasized until the 1800's (20). Active research 
into the association of group A, beta-hemolytic strepto-
coccal infections with glomerulonephritis did not commence 
until the 1950's, when Rammelkamp and Weaver (92) showed 
that only certain, so-called "nephritogenic" strains of 
streptococci, representing several M-types, led .to the renal 
lesions of glomerulonephritis. The exact nature of these 
strains and the reasons for their nephritogenicity have 
been the focus of much research since then, but this has 
yielded little in the form of widely accepted conclusions. 
Several forms of glomerulonephritis are immunologic 
1 
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diseases. This was shown as early as 1933 by Masugi (69), 
who induced disease in experimental animals with anti-
kidney antiserum in what are now considered classic experi-
ments. The first direct evidence that the site of the 
nephrotoxic antigen was located in the glomerulus was pro-
vided by Greenspon and Krakower (29) in 1950. They showed 
that rabbit antisera produced against isolated, purified 
canine glomeruli induced glomerulonephritis when admini-
stered to dogs. Further investigations have shown that the 
glomerular basement membrane (GBM) contains the antigens 
capable of eliciting nephrotoxic antisera (35, 47, 60, 62, 
65, 106, 113). Krakower and Greenspon (47) were also first 
to show that antisera raised against canine GBM produced 
nephritis in dogs. 
By immunofluorescence and electron microscopy it can 
be shown that both gamma globulins (IgG, IgA or IgM) and 
complement components (usually C'3, or~1c) are deposited 
in a "linear" (i.e., filling the GBM) staining pattern 
along the GBM, both in experimental immune nephritis and in 
patients with the d.isease. It has also been shown that the 
nephrotoxicity of GBM antigens are not species specific, 
since antisera and GBM antigens from one animal species can 
induce glomerulonephritis in an unrelated species (65, 106). 
Thus Steblay and Lepper (105,. 106) have shown that there is 
an antigenic relationship between human and dog GBM, and 
3 
antiserum to human GBM is capable of inducing nephritis in 
dogs. The composition and immunologic properties of glo-
merular basement membrane have therefore been the focus of 
an extensive amount of research. 
B. Glomerular Basement Membrane 
Glomerular basement membrane has been characterized 
as a collagen or "collagen-like" material (17, 35, 39, 41, 
56, 81) because of its high content of hydroxyproline. It 
differs from collagen, however, in that it contains less 
glycine, proline and hydroxyproline and more hydroxylysine 
and cystine (41). In addition, the total carbohydrate con.-
tent of basement membrane is much higher (41), being about 
10% of its dry weight as compared to about 0.6% in collagen 
(40, 41, 53). It has been suggested that there are two dis-
tinct components of basement membrane, the collagen or col-
lagen-like substance, and a glycoprotein (17, 35, 41). Dif-
ferences of opinion at first existed as to whether carbohy-
drate moieties were attached to the collagen-like material 
or only to the glycoprotein (41, 104). In addition, there 
may be more than one type of glycoprotein in GBM (39). 
Dische et al. (17) first showed that two different 
polysaccharide units were present in human GBM. One was 
characterized as a disaccharide, containing glucose and gal-
actose, attached to the collagen-like, material, and the other 
a heteropolysaccharide, containing sialic acid, fucose and 
4 
hexose, not associated with collagen. Misra and Kalant (82), 
on the other hand, found that a sialic acid containing hete-
ropolysaccharide in rat GBM was attached to the collagenous 
substance via hydroxyproline. The discrepancy was cleared 
up by the elegant studies of Spiro (103, 104), who digested 
bovine GBM with pronase and collagenase, yielding small gly-
copeptide fragments containing only a few amino acid resi-
dues. Two major glycopeptides were found. One consisted of 
the glucosyl-galactose disaccharide unit attached to hydro-
xylysine, while the other was a heteropolysaccharide unit 
consisting of galactose, mannose, hexosamines, sialic acids 
and fucose, probably attached to asparagine. He also esti-
mated that there were 59 sugar residues for every 1000 amino 
acids, and the ratio of the disaccharide to heteropolysac-
charide moieties was 10 to 1. Approximately 70% of the 
hydroxylysine residues were involved in linkage to the dis-
accharide. The major findings of Spiro were subsequently 
confirmed by Kefalides (39), who also showed that the disac-
charide unit was attached to the collagen-like substance of 
the GBM, while the heteropolysaccharide existed as part of a 
separate glycoprotein. Kefalides (39, 40) also found a third 
glycoprotein antigen, also a heteropolysaccharide containing 
compound, and concluded from immunological studies that glo-
merular basement membrane has at least 3 major glycoprotein 
antigens. 
pt 
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C. Nephrotoxic Antigens of GBM 
The nephrotoxic ability of the glycoprotein antigens 
of GBM has led to some controversy. Several investigators 
(35, 68, 80) have found that the major nephritogenic antigen 
is contained in the sialic aoid containing glycoprotein, 
while another (60) has presented evidence indicating that it 
is the site at which the glucosyl-galactose component is 
linked to the collagen-like substance. Huang and Kalant (J5) 
isolated 6 components of rat GBM by co-1.lagenase digestion, 
urea extraction and Sephadex chromatography. Only one of 
the glycoprotein components isolated proved to be nephrito-
genic. It contained 10.7% carbohydrate in the form of gal-
actose, mannose, glucosamine, galactosamine and sialic acid. 
Mcintosh et al. (73) isolated a urinary glycoprotein from 
rats which subsequently was shown to be identical to a GBM 
antigen. The urinary glycoprotein was found to contain 
sialic acid, glucose, galactose, mannose and fucose, and was 
non-collagen-like in nature. Antiserum to this urinary gly-
coprotein was shown by immunofluorescence to localize on the 
rat GBM. Collagen did not absorb out the capacity of the 
anti-urinary glycoprotein antiserum to localize in the GBM, 
while GBM and whole glomeruli could. Misra (80), upon iso-
lation of several soluble fractions of rat, dog and human 
GBM, found nephrotoxic ability associated with a sialoglyco-
protein of 50, 000_ dal tons. GBM collagen and several other 
p 
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glycoprotein antigens isolated from the same starting mate-
rial were found to elicit antibodies which localized in the 
glomerulus but which failed to induce disease symptoms. 
Marquardt et al. (68) identified 7 distinct antigenic com-
ponents of human GBM. Subsequent fluorescent antibody ab-
sorption studies with antibodies eluted from kidneys of 
patients with glomerulonephritis showed that blocking acti-
vity was located in a non-collagen antigen, while collagenous 
GBM had no activity. 
In co"ntrast to the above studies, Mahieu et al. (60) 
presented equally convincing evidence that nephritogenicity 
is associated with the glucosyl-galactose residue attached 
to the hydroxylysine of collagenous GBM. They isolated both 
the disaccharide and heteropolysaccharide containing glyco-
peptides from human GBM. Using inhibition of the formation 
of antigen-antibody complexes in radioimmunosays as a test, 
it was found that only the disaccharide-containing glycopep-
tide inhibited the formation of radioactive GBM-anti-GBM 
antibody complexes, when antisera from glomerulonephritic 
patients was used. In addition, leukocytes were obtained 
from several patients with glomerulonephritis and again only 
the disaccharide-containing glycopeptide inhibited leukocyte 
migration, indicating that it contained the major antigenic 
site involved in nephritis. The determinant responsible for 
the antigenicity _was found to reside in the galactose-hydro-
7 
xylysine moiety of the glycopeptide. The heteropolysaccha-
ride, containing galactose, mannose, hexosamines, fucose and 
sialic acid, but no hydroxylysine or hydroxyproline, showed 
little or no antigenic activity in the two tests. 
D. Glomerulonephritis 
Although the pathogenesis of some forms of glomerulo-
nephri tis involves specific kidney antigens and anti-kidney 
antibodies, another form, though immunologic in nature, is 
entirely non-specific with regard to glomerular or GBM anti-
gens. Glomerulonephritis caused by soluble immune complexes 
was first noted as a consequence of experimental serum sick-
ness (28, 98). Miller et al. (79) subsequently were able to 
produce glomerulonephritis in mice by injections of soluble 
ovalbumin-anti-ovalbumin complexes, using antisera produced 
either in mice or rabbits. Dixon et al. (19) were also able 
to produce immune-complex glomerulonephritis in rabbits by 
repeated injections of either bovine or human serum albumin, 
and bovine or human gamma globulins. They found that the 
types of glomerulonephritis produced were similar to the 
human acute, proliferative and chronic glomerulonephritidies, 
and were dependent upon the amounts of antibody produced in 
response to the antigen injected. High titers of antibody 
resulted in the acute type of disease, while low titers were 
associated with proliferative or chronic glomerulonephritis. 
In all cases immunofluorescent studies showed that both 
p 
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antigen and antibody were located in the glomerulus in a 
"granular" (i.e., dispersed along the GBM) pattern. Electron 
microscopic studies showed deposits of electron dense mate-
rials, presumably complexes, on the epithelial side of the 
basement membrane. Subsequent characterizations of naturally 
occurring glomerulonephritides, in both man and animals, as 
immune-complex mediated has relied on this initial charac-
terization of the disease by Dixon et al. Kidney glomeruli 
showing granular staining by immunofluorescence or "lumpy" 
deposits by electron microscopy have invariably been char-
acterized as immune-complex lesioned. Thus Markham et al. 
(61) ascribed to subclinical immune-complex glomerulonephri-
tis the disease occurring spontaneously in mice, on the basis 
of observed granular-type fluorescent antibody staining pat-
tern found for IgG, IgM, IgA and complement in their glome-
ruli. Keslin et al. (4J) also concluded that there was an 
immune complex glomerulonephritis due to Streptococcus mi tis 
in a patient with subacute bacterial endocarditis, caused by 
the same organism, because of the observation that the 
patient's glomeruli stained in a "lumpy-bumpy" pattern for 
IgG and complement by a fluorescent antibody test. Tornroth 
and Skrifvars (108) described glomerulonephritis associated 
with a case of cryoglobulinemia because the patients' glo-
meruli showed subepithelial deposits of electron dense mate-
rial. They attributed glomerulonephritis to complexes of 
, 
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cryoglo bulins. Tung ( 112) , and Poskitt e.t al. ( 88) described 
naturally occurring immune-complex deposits in mice, guinea 
pigs and monkeys on the basis of .their observance of granu-
lar fluorescent staining patterns and electron dense epithe-
lial cell deposits in the animals' respective glomeruli. 
Much more comprehensive evidence for naturally occur-
ring immune-complex glomerulonephritis exists. Lambert and 
Dixon (49) described the pathogenesis of immune-complex glo-
merulonephri tis in NZB/W mice. The development of the dis-
ease vms found to follow closely the formation of anti-
nuclear antibodies. By immunofluorescence they were able to 
demonstrate the presence of nuclear antigens, antibody and 
complement in a granular pattern in the glomeruli. Injection 
of mouse DNA into the experimental mice hastened the develop-
ment of the disease and intensified the severity of nephri-
tis. Finally, antibodies eluted from the mice glomeruli were 
found to have anti-DNA activity. Similar results have been 
reported by Koffler et al.(45) for glomerulonephritic 
patients with systemic lupus erythematosus. Porter et al. 
(87) showed that antibodies eluted from the glomeruli of 
C57BL/6 mice which had developed spontaneous glomeruloneph-
ri tis were active against murine leukemia virus, suggesting 
that the immune-complexes were viral-anti-viral antibody in 
nature. Costanza et al. (11) and Poskitt et al. (89) have 
demonstrated the .presence of gamma globulins and tumor anti-
10 
gen deposits in the glomeruli of a patient with colonic car-
cinoma and in mice with melanomas, respectively. Brzoska 
et al. (8) and Kohler et al. (46) have reported the detec-
tion of hepatitis B antigen-anti-hepatitis B antibody com-
plexes in glomerulonephritic patients suffering from hepati-
tis. In both studies granular fluorescent staining was seen 
with anti-gamma globulin, anti-~1c and anti-hepatitis B an-
tigen antisera. In addition Kohler et al. (46) were able to 
demonstrate the presence of circulating soluble complexes of 
hepatitis B antigen and anti-hepatitis B antibody by cryo-
precipitation using a patient's serum. 
E. Post-Streptococcal Glomerulonephritis 
The detailed pathogenic mechanisms involved in post-
streptococcal glomerulonephritis remain obscure, in part 
because of contradictory experimental results and also be-
cause of differences in interpretations. It is well docu-
mented (7, 13, 91, 92, 124) that only certain streptococcal 
M-types induce glomerulonephritis. Thus, of the 61 known 
M-types, those having been report~d to lead to glomerulo-
nephri tis, in man or experimental animals are types 1 (7), 2 
(2, 13, 15, 92)' 4 (91, 92), 12 ( 7, 32, 42, 91, 102), 49 
(7, 13, 24, 86, 91, 92), 55 (55, 86), 57 (22), 59 ( 13, 14), 
60 (13, 14) and 61 ( 14). Of these, type 12 accounts for 80 
percent or more of the strains isolated from cases of post-
streptococcal gl0merulonephritis (114). 
11 
Evidence that human streptococcal-related glomerulo-
nephri tis is an immunological disease is well documented. 
Patients with the disease generally have a high anti-strep-
tolysin 0 (ASO) (16) or anti-DNAse B titers (16) and low 
serum complement levels (23, 124). There is a latent period 
between the initial infection, either pharyngitis or pyoder-
ma, and the onset of glomerulonephritic symptoms (7, 115). 
This has also been reported in an experimental study by 
Vosti et al. (115). They reported that initial symptoms 
occurred within seven days of infection, followed by another 
latent period of 21 days or more, leading to severe glomeru-
lonephritis in rats exposed to nephritogenic group A strep-
tococci. These observations have been confirmed by Becker 
and Murphy (7) in rabbits. There is usually no correlation 
between the gravity of the initial pharyngitis or pyoderma 
and the occurrence or severity of glomerulonephritis (20). 
Group A streptococci are not always found in the throat, 
skin, blood or kidneys of patients who have developed glo-
merulonephri tis (20). Immunofluorescent studies invariably 
show the deposition of immunoglobulins, usually IgG or IgM, 
and complement in a granular pattern, although a linear 
arrangement has also been noted, along the basement membrane 
or in mesangial areas of patient's glomeruli (5, 78). Poly-
morphonuclear leukocytes and macrophages are often prevalent 
in the lesion (20). Electron microscopic studies have fre-
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quently demonstrated subepithelial deposits of electron dense 
materials (5, 78), as well as mesangial deposits (5). Thus 
post-streptococcal glomerulonephritis presents similar char-
acteristics to other immunological glomerulonephritidies. 
There are many theories on the pathogenesis of post-
streptococcal sequelae. Most attempt to explain the disease 
as either immune-complex mediated or kidney-reactive anti-
body-mediated. However, there is no conclusive evidence on 
the exact pathogenic pathway involved-: 
Evidence for the soluble immune-complex mediation of 
human post-streptococcal glomerulonephritis lies mainly in 
the granular-fluorescent staining pattern of gamma globulins 
and complement in the glomeruli of patients (5, 78, 100, 124), 
and in the presence of electron-dense subepithelial deposits 
(5, 31, 78). Such findings are consistent with observations 
made in experimental immune-complex nephritis. Additional 
evidence comes from the findings of Seegal et al. (101), 
Andres et al. (1), Michael et al. (77) and the report of 
Zabriskie (124), who demonstrated that in addition to bound 
gamma globulins and complement, some post-streptococcal glo-
merulonephritis patients had streptococcal antigen& bound in 
their glomeruli. However, in at least one study (77) strep-
tococcal antigens were located in mesangial areas in contrast 
to the GBM bound immunoglobulins. In contrast to this 
McCluskey et al. (71) and Feldman et al. (21) were unable to 
find deposits of streptococcal antigen, using similar tech-
p 
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niques, in biopsy specimens that showed bound gamma globulins 
and complement. The production of glomerulonephritis in ani-
mals by the injection of pre-formed complexes, as has been 
reported using several other foreign antigens, has not been 
reported with the use of streptococcal antigen-anti-strepto-
coccal antibody complexes. 
A modified-immune complex theory, first suggested by 
Lipman (58), envisions streptococcal products first lodging 
in the glomerulus, followed by their interaction with spe-
cific anti be.dies, and the subsequent activation of comple-
ment, infiltration of polymorphonuclear leukocytes and glo-
merular damage. Evidence for this theory comes from the work 
of Treser et al. (109, 110, 111), who reported (109) that 
fluorescein-conjugated IgG from patients with acute post-
streptococcal glomerulonephritis would stain the glomeruli 
in a granular pattern, of sections taken from biopsy speci-
mens of such patients, but would not stain the glomeruli of 
normal kidney sections or of sections taken from biopsies of 
patients with other renal diseases. They found that the 
staining capacity could be absorbed from the sera with group 
A,~ -hemolytic nephritogenic streptococci, but not with non-
nephritogenic streptococcal strains or with other species of 
bacteria. In addition, after separating the cell walls and 
cell membranes of the nephrit~genic streptococci, they found 
absorbing activity associated only with the cell membrane 
f 
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fraction. Antisera made in rabbits against the purified 
cell membranes were found to have similar staining capaci-
ties to the patients sera, in fluorescent antibody tests 
using sections from the same biopsy specimens. The authors 
concluded that those patients with acute post-streptococcal 
glomerulonephritis had cell membrane antigens lodged in 
their glomeruli, and the corresponding antibodies in their 
serum, which led directly to the clinical manifestations of 
their renal disease. In subsequent communications (110, 111) 
they reported that the isolated glomeruli from normal human 
kidney would not absorb out the staining capacity of the 
patients antisera, while the cell membranes of type 12, 49, 
and an untypable strain isolated from cases of the disease 
would, regardless of the type of streptococcus that origi-
nally caused the disease. The cell membranes of non-nephri-
togenic strains J, 4, 6, 12, 14 and 25 had no absorptive 
capacity. The conclusion was drawn that nephritogenic strep-
tococcal strains 12, 49 and the untypable strain, as well as 
other nephritogenic strains, had ~ distinct antigen in their 
cell membranes which was not possessed by non-nephritogenic 
streptococci, and this antigen had some kind of predilection 
or tropism for the glomerulus or glomerular basement mem-
brane. 
In contrast to the findings of Treser et al. other 
investigators have found that the M-protein of the cell wall, 
p 
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and not cell membrane antigens, were bound in the glomeruli 
of patients with post-streptococcal glomerulonephritis or in 
experimental animals in which the disease was induced. Thus 
Seegal et al. (101) found that fluorescein-conjugated anti-
body to type 12 streptococci bound to the glomeruli of 6 out 
of 10 patients with glomerulonephritis. In addition, they 
purified type 12 M-protein, conjugated it·with fluorescein, 
and found that it, too, bound to the glomeruli of 6 of 10 
patients with the disease. They concluded that M-protein was 
bound in the glomeruli, as well as excess anti-M-protein anti-
bodies, which allowed the further binding of fluorescein-
conjugated M-protein. Lindberg and Vosti (57), and Vosti et 
al. (115) were able to induce glomerulonephritis in rats by 
the intraperitoneal implantation of diffusion chambers con-
taining live, type 12 streptococci. Subsequent fluorescent 
antibody studies on sections of kidneys taken from the rats 
showed the deposition of gamma globulins, complement and M-
protein in their glomeruli. In addition, eluted antibodies 
from the rat kidneys were reported to react specifically with 
type 12 M-protein, by hemaglutination tests. Both Seegal et 
al. and Vosti et al. assumed that the M-proteins were lodged 
as part of pre-formed antigen-antibody complexes, rather than 
being first deposited in the glomerulus and subsequently 
reacting with antibody, as in the theory of Treser et al. 
One of th& earlier theories.concerning the pathogene-
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sis of post-streptococcal glomerulonephritis assumed that 
nephritogenic streptococci elaborate toxic products which 
act directly on kidney structures. In 1958 Kelly and Winn 
(42) reported that the implantation in mice of diffusion 
chambers containing nephritogenic type 12 or non-nephrito-
genic types 3, 36 and group C streptococci, caused renal 
lesions only in the mice exposed to type 12. Extensive pro-
ximal tubule necrosis as well as glomerular abnormalities 
were seen. Since whole cells could ne-t get out of the cham-
bers, it was assumed that toxic products caused the damage. 
Matheson and Reed (70) extended these observations in rab-
bits. They injected either type 12 streptococci or filtra-
tes from broth cultures of type 12·streptococci into rabbits 
and noted that in either case, only tubular damage resulted. 
Washed type 12 streptococci did not produce renal disease. 
The tubular destroying factor was found to precipitate in 
65-70% ammonium sulfate, from cell-free culture filtrates. 
Tan and Kaplan (107) subsequently characterized .the tubular-
necrotic factor as streptolysin S. After implantation of 
diffusion chambers containing live type 12 streptococci in 
mice, renal tubular lesions were noted. Using a fluorescent 
antibody test, they looked for the deposition of streptococ-
cal antigens in either tubules or glomeruli with anti-whole 
streptococcal antisera. No deposition was found. In pas-
sive protection experiments in which mice first received 
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anti-streptococcal antisera, no prevention of tubular lesions 
was noted. They then attempted to induce the tubular lesions 
with cell-free filtrates from cultures grown in the absence 
of serum. No lesions were induced. They concluded that the 
observations were consistent with a toxic effect of strepto-
lysin S, since this enzyme is relatively non-antigenic and is 
not produced in broth unless serum is added. To test this 
hypothesis, they repeated the diffusion chamber experiments 
using a streptolysin-S deficient mutant of streptococci. It 
failed to induce tubular damage. Finally, purified strepto-
lysin S was injected intraperitoneally into mice. Renal 
tubular necrosis was found similar to that found in the dif-
fusion chamber experiments. 
Since streptolysin S acted only on tubules and did not 
seem to affect glomeruli, its role in post-streptococcal glo-
merulonephritis is questionable. It has been proposed that 
the enzyme may be responsible for the early mild proteinuria 
seen in the clinical and experimental disease states (115). 
Bayatpour et al. (6) have suggested that post-strep-
tococcal glomerulonephritis could result from the combined 
effect of previous streptococcal infection followed by a 
viral infection. They reported a case of glomerulonephritis 
in which the patient had an elevated ASO titer, and coxsac-
kievirus B4 was isolated from ~is blood, urine, stool, nose 
and throat. They concluded that the virus was playing the 
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major role in the disease, in that it probably "activatecl" 
lodged streptococcal antigens present in the glomerulus. In 
addition, they theorized that the preceding streptococcal in-
fection somehow predisposed renal tissue to localization and 
multiplication of virus, which then causes glomerular damage. 
Mcintosh et al. (72) have presented evidence for a 
unique theory concerning the pathogenesis· of post-streptoco-
ccal glomerulonephritis. They took autologous serum samples 
or isolated autologous IgG from rabbits and treated them with 
cultures of group A~-hemolytic streptococci. After centri-
fugation and filtration of samples to remove bacteria, the 
serum or IgG samples were re-introduced into the rabbits. 
The same was cone with control rabbits, except that the serum 
or IgG samples were not exposed to streptococci. Fifty per-
cent of the rabbits receiving streptococcal-treated serum or 
IgG developed clinical symptoms of glomerulonephritis, in-
cluding hematuria, proteinuria and glomerular lesions with 
demonstrable IgG and complement deposits along their GBM. 
Control animals showed no abnormalities. They suggested 
their results demonstrated that streptococcal products can 
act on IgG, causing it to become auto-immunogenic. Subse-
quent antibodies made against the now antigenic IgG could 
lead to complex formation and renal disease. An alternative 
suggestion was that the action of streptococcal products 
caused the IgG to itself have the piological characteristics 
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of a complex, and directly have the capacity of initiate 
renal damag-e. The authors had previously shown that treat-
ment of rabbit IgG with a-hemolytic streptococci altered its 
carbohydrate content, including a marked reduction in the con-
tent of hexose, sialic acid a.nd fucose (74). They suggested 
that enzymes produced by the organism were responsible for 
the alteration. 
A major hypothesis on the pathogenesis of glomerulo-
nephri tis by certain streptococci, foF~which experimental 
evidence exists, calls for the occurrence of antigens on the 
glomerular basement membrane of some individuals that cross-
react with antigens of the streptococcal cell membrane of 
some strains of streptococci ( 67). · The theory that bacterial 
cells may contain antigens cross-reactive with mammalian tis-
sues is not new. Asherson (J) has summarized the experimen-
tal findings which indicate cross-reactive relationships be-
tween several gram negative bacteria and human blood group 
antigens. The gram negative bacteria included E. coli, Sal-
monella, Klebsiella, Citrobacter, Pasteurella, Proteus, Pseu-
domonas, Serratia and Alcaligenes. Various strains of pneu-
mococci also share antigens with human A and O blood group 
antigens. E. coli strain 014 contains antigens related to 
the colonic mucosa of rats and rabbits, and this may play a 
role in the pathogenesis of ulcerative colitis. Antisera 
made against seve~al types of pneumococcal polysaccharides 
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react with some purified mammalian glycogens, especially of 
the horse. 
Several investigators have demonstrated immunological 
cross-reactions between nephri togenic group A, ~-hemolytic 
streptococci, and kidney antigens of humans (33, 34, 44, 50, 
66, 67, 122), dogs (95, 96), mice (102), rats (63), guinea 
pigs (50) and rhesus monkeys (62, 64). In addition, anti-
gens of, or antisera made against group A streptococci have 
been reported to cross-react with antigens or tissues of 
human heart "(27, 37, 38, 45, 122), lung (33), skin (44), 
fibroblasts (44), astrocytes (44) and skeletal muscle (44, 
122), as well as guinea pig skin (10, 52, 93, 94), heart (59), 
muscle (59) and liver (59). 
Markowitz and Lange (66) first showed that soluble 
components isolated from pooled human glomeruli and from 
nephritogenic type 12 streptococci were antigenically rela-
\ 
ted, using passive hemagglutination and passive cutaneous 
anaphylaxis techniques. They expanded their studies (67) 
to show that trypsin solubilized extracts of pooled human glo-
meruli and type 12 streptococcal cell membranes (SCM) were 
reciprocally cross-reactive in immunociffusion, passive cuta-
neous anaphylaxis and passive hemagglutination experiments, 
using antisera made ag·ainst either pooled human glomeruli, 
human glomerular basement membrane, the soluble extract of 
human glomeruli, _solubilized extracts of type 12 streptoco-
ccal cell well/membrane preparations, or a soluble prepara-
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tion of streptococcal cell membrane. Similar soluble prepa-
rations of non-nephritogenic types 11 and 14 streptococci 
yielded no cross-reactions with the human glomerular mate-
rials or antisera. The cross-reactive soluble extracts of 
both human glomeruli and type 12 streptococcal cell membranes 
were found to contain protein and carbohydrates, suggesting 
the presence of glycoprotein antigens. Further chemical and 
immunological characterizations of the cross-reacting soluble 
components by Lange and Markowitz (54) and Lange (52) showed 
both to be composed of approximately 80% protein and 20% 
carbohydrate. Peptide maps of the materials, made after 
papain digestion, were found to be extremely similar, in fact, 
almost superimposable. Lange (50) attempted to extract cross-
reacting soluble components of group A, type 12 SCM and pooled 
human GBlV! by v'arious solubilization procedures. Those used 
included sodium lauryl sulfate (SLS), trichloroacetic acid 
(TCA), cyanogen bromide (CnBr), sodium deoxycholate (DOC), 
lipase, Triton X-100, chloroethanol (Cl-EtOH), trypsin, pep-
sin and collagenase. Of these, only SLS, CnBr, DOC and tryp-
sin yielded soluble cross-reacting components from type 12 
cell membranes, and only CnBr and trypsin yielded similar 
soluble antigens from GBM. Solubilized cross-reacting anti-
gens from GBM and SCM were chromatographed to DEAE-cellulose 
columns and the bulk of cross-reactivity came off in the first 
peak for both preparations. Subsequent papain digestion of 
22 
peak I materials, peptide mapping and elution of peptides 
yielded several fractions which showed reciprocal cross-
reacti vi ty by immunodiffusion and passive hemagglutination, 
using antisera made against either the soluble SCM extract 
or the soluble glomerular extract, Carbohydrate analysis of 
all cross-reacting peptides demonstrated hexose, hexosamine 
and sialic acid from the GBM derived peptides, and hexose 
and hexosamine from the SCM derived peptides. It thus seemed 
that the cross-reactive antigens from-both human glomeruli 
and type 12 SCM were glycoproteins. 
The relationship between the cross-reactivity of GBM 
and type 12 SCM to glomerulonephritis has been demonstrated 
in three experimental animal systems. Markowitz et al. (63) 
first demonstrated that antiserum made against an antigenic 
extract of type 12 streptococci, when inoculated into rats, 
produced glomerular lesions. Markowitz (62) and Markowitz 
et al (64,65) later showed that antisera made against the 
cross-reacting trypsin solubilized components of human glom-
eruli and type 12 SCM produced glomerulonephritis when either 
perfused into Rhesus monkey kidneys or injected into the 
whole animal. The nephritis induced with antiserum to the 
GBM component was found to show IgG localization with a 
fluorescent linear staining pattern along the GBM, while the 
SCM antiserum resulted in granular localization of IgG. In 
addition, immunization of Rhesus monkeys with either the 
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soluble glomerular antigen or the soluble.SCM antigen resulted 
in glomerulonephritis, again with linear staining for IgG 
following immunization with the glomerular preparation, and 
granular localization of IgG following inoculation of the SCM 
preparation. It was conclude,d that post-streptococcal glom-
erulonephri tis could not be classified as an immune-complex 
disease based on the observation of a fluorescent granular 
staining pattern in the glomerulus, since the administration 
of SCM antigens or antiserum resulted-in the same type of 
pattern. Rather, it was suggested that the disease resulted 
from a cross-reaction between GEM and antibodies made against 
SCM antigens. 
Rapaport et al. (95,96) conducted similar experiments 
in dogs. In two separate sets of experiments isolated dog 
kidneys were perfused with antiserum made against type 12 
streptococcal cell membrane and then reimplanted into the 
original donors (autografts). 12 out of 14 and 13 out of 16 
dogs developed glomerulonephritis or glomerular abnormalities, 
including albuminuria, glomerular swelling and hypercellu-
larity, infiltration of polymorphonuclear leukocytes, and 
deposition of IgG on their glomerular basement membrane. All 
controls were negative. In one experiment (95), the pattern 
of fluorescent staining was linear along the GEM, while in 
the other (96) it was granular. In other experiments, the 
isolated gamma glpbulin fraction from an antiserum made 
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against a trypsin soluble extract of type 12 SCM was simi-
larly perfused into the kidneys of 9 dogs. Eight of the dogs 
developed glomerulonephritis. 
Zabriskie et al. (126) have provided evidence of a 
possible role of cellular hypersensitivity to type 12 strep-
tococcal cell membrane antigens in causing glomerulonephritis. 
They showed that streptococcal cell membranes, but not cell 
walls, caused significant inhibition of migration of leuko-
cytes from patients with glomerulonephritis. Leukocytes from 
patients with non-glomerular diseases or from normal individ-
uals showed little or no cellular reactivity to streptococcal 
antigens. In addition, streptococcal cell membrane was found 
to stimulate DNA synthesis in the isolated lymphocytes of 
glomerulonephritic patients, but little or no stimulus was 
found in the controls. They considered it possible that in-
fection with type 12, group A streptococci, besides initi-
ating antibody synthesis, could sensitize leukocytes to SCM 
antigens, and such leukocytes would then be capable of at-
tacking glomeruli at the site of cross-reactivity. 
F. Cross-Reactions with Other Mammalian Tissues 
The cross-reaction between a streptococcal antigen and 
antigens present in another organ, the heart, has been pro-
posed as a main pathogenic factor in another streptococcal 
initiated disease, rheumatic fever. An antigenic relation-
ship between group A,~-hemolytic streptococci and human 
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heart has been reported by se_veral investigators (27, 37, 38, 
44, 122). However, the site of the cross-reacting antigens in 
the bacteria and the heart muscle have led to some' controversy. 
Kaplan and Svec (38) and Kaplan (37) have demonstrated that an 
antigen associated with the cell walls of M-types 5 and 19 
streptococci are capable of absorbing heart-reactive antibodies 
from the sera of patients with rheumatic fever and rheumatic 
heart. In addition, antiserum made against the cell wall anti-
gen from types 5 and 19 streptococci reacted with cardiac 
myofibers, smooth muscle of vessel walls, and striated muscle, 
in immunofluorescence and complement-fixation tests. The anti-
gen, which was closely associated with, but not identical to, 
the M-proteins of the two types of streptococci, was not found 
in strains of types 1, .3, 6, 8, 11, 12, 25, or 49 group A 
streptococci, .and not in strains of groups C, D, and G. 
In contrast to Kaplan's findings, Zabriskie and Freimer 
(125) found,by immunofluorescence, a cross-reactive antigen 
with human heart sarcolemma membrane in all 21 strains (M-
types) of group A streptococci they tested. They also found 
that the cross-reactive antigen was associated with the cell 
membranes, not the cell walls, since the antisera were pre-
pared against the cell membranes of the organisms. Also, the 
reactivity of the antisera could be absorbed out with cell 
membranes but not cell walls, and antisera made against pur-
ified M-proteins had no reactivity with heart tissue, by 
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fluorescent antibody tests. ~reimer (25, 26) had previously 
demonstrated by immunodiffusion tests that the cell membranes 
of M-types 1, 3, 6, 12, 14, 22, 25, and 50 streptococci con~ 
tained an identical antigen. 
Another phenomenon elicited by group A streptococci, 
which may be related to a cross-reacting antigen with mamal-
ian tissues, is the acceleration of skin-graft rejection 
(white-graft) in guinea pigs. Chase and Rapaport (10) inject-
ed heat-killed M-types 4, 5, 6, 11, 12, 14 and 49 strepto-
cocci into the skin of guinea pigs, and then transplanted 
skin from unrelated donors to the same site. The graft re-
jection was accelerated in a manner identical to that seen 
following sensitization of guinea pigs with homologous tissues. 
This phenomenon was also found to be associated with Staphy-
/ 
lococcus aureus and Staphylococcus albus, but not with strep-
tococci of groups B, C, D, E, H, L, and 0, or with pneumo-
cocci types 2 and 3, Corynebacterium xerosis, Bacillus sub-
tilis, E. coli, Aerobacter aerogenes, Salmonella typhimurium, 
Proteus vulgaris, Neisseria catarrhalis, Hemophilus influ-
enzae, or Mycobacterium tuberculosis. Rapaport et al. (94) 
later showed that antiserum to group A, M-type 12 SCM, but 
not cell walls, could produce similar graft-rejection accel-
eration in guinea pigs, whether injected intradermally into 
the site of skin allografts, intravenously, or intraperito-
neally. In addition, anti-SCM antisera, when combined with 
epinephrine and injected intradermally, caused local hemor-
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rhagic necrosis in guinea pigs. Lange (52) confirmed this 
observation, and further reported on the necrotizing activity 
of several antisera made against soluble extracts of type 12 
streptococcal cell membrane. Thus hemorrhagic necrosis was 
found to be induced with antisera made against whole SCM and 
with soluble extracts prepared from treatment of SCM with 
sodium lauryl sulfate (SLS), pepsin and cyanogen bromide, 
and SLS, CnBr and pepsin. Antisera prepared against soluble 
extracts of SCM by citric acid, cyanogen bromide, or SLS and 
CnBr failed to produce necrosis. 
G. Immunochemical Studies 
Chemical analyses of cross-reacting antigens of strep-
tococci and mammalian tissues has in most instances shown 
them to be glycoprotein in nature (50,54,67), The question 
therefore arises as to the chemical nature of the antigenic 
determinants which cross-react. Are they carbohydrate or 
protein in nature, or a combination of both? Markowitz and 
Lange (66) and Lange (50) originally emphasized the role of 
carbohydrate groups. However Quish and Lange (90) have re-
cently shown that the antigenicity of human glomerular base-
ment membrane, as well as of a urinary glycoprotein, increases 
after cleavage of their carbohydrate units with carbohydrases. 
Precipitin analyses were used to quantitate the antibody in 
homologous antisera. More antibody was found with carbohy-
drase-treated glypoprotein antigens than with the correspond-
, 
28 
ing untreated antigens. In addition, the supernatants of 
precipitin reactions in which untreated antigens were used 
were found to contain antibodies which reacted with the car-
bohydrase treated antigens. It was thus suggested that some 
antigenic sites on the glycoproteins were wholly or partially 
masked by carbohydrate units. Athineos et al. (4) had pre-
viously shown that another glycoprotein antigen, orosomucoid, 
increased in antigenicity following desialization with neur-
aminidase. 
H. Purpose of Present Work 
As can be seen from the literature, the current sta-
tus of the understanding of the pathogenesis of post-strep-
tococcal glomerulonephritis is confusing at best. Most 
theories stand either unproven, untested, unconfirmed or un-
refuted. This work was undertaken, therefore, to partially 
examine one theory, that of a cross-reaction between group A, 
type 12 SCM and human (and mouse) GBM. In order to assess 
the nature of the cross-reaction, 22 anti-SCM antisera, made 
in rabbits, representing seven chemically defined soluble 
SCM preparations, have been evaluated by indirect immuno-
fluorescence and absorption tests for their reactivity to 
sections of human and mouse kidney cortex. In addition, ten 
anti-human glomerular antisera, representing six antigenic 
preparations, have been similarly evaluated. The possible 
potentiation of cross-reactivity between the antisera and 
glomeruli or GBM, by treatment of sections or antigens with 
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carbohydrases, was evaluated. The antisera were also tested 
by immunodiffusion techniques for reactivity to chromato-
graphically isolated fractions of SCM and human GBM. 
CHAPTER II 
MATERIALS AND METHODS 
A. Antisera 
All antisera had been previously prepared in rabbits 
and had been tested for antigenic specificity before being 
used (51,52). For antisera preparation, each rabbit re-
ceived 5 mg of an antigen over a 21 day period. The first 
inoculation consisted of 2.0 mg antigen in complete Freund's 
adjuvant, distributed in the foot pads and subcutaneously. 
The second inoculation, 14 days following the first, was of 
2.0 mg antigen in incomplete Freund's adjuvant, given intra-
muscularly. The final inoculation~ of 1.0 mg antigen, was 
given in incomplete Freund's adjuvant, intramuscularly, 7 
days following the second inoculation. The rabbits were bled 
one week after the last inoculation. 
In all, 22 antisera, prepared in 22 separate rabbits 
against group A, type 12 SCM (strain Hektoen, isolated from 
a patient with post-streptococcal glomerulonephritis) or 
soluble extracts of SCM, were used. Seven chemically de-
fined preparations of SCM were used to obtain the antisera. 
They included whole, insoluble SCM (seven antisera, from 
rabbits number 16, 19A, 20A, 23, 25, 29 and 37), the soluble 
fractions isolated from treatment of SCM with sodium lauryl 
sulfate (SLS-SCM. four antisera, numbers 2, 4, 10 and 17), 
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cyanogen bromide (CnBr-SCM, one antiserum, number 18), pep-
sin (two antisera, numbers 24 and 30), pepsin and cyanogen 
bromide (pepsin-CnBr-SCM, two antisera, numbers 3 and 15), 
sodium lauryl sulfate and cyanogen bromide (SLS-CnBr-SCM, 
four antisera, numbers 9, 19B, 21 and 27) and the second 
peak isolated from DEAE-cellulose chromatography of sodium 
lauryl sulfate solubilized SCM (SLS-SCM II, two antisera, 
numbers 22 and 28). 
Ten antisera, prepared against :12_?oled adult human 
glomeruli, GBM or soluble extracts of·glomeruli or GBM were 
also used. They included whole glomeruli (Gloms, two anti-
sera, from rabbits number 8 and 11), glomerular basement 
membrane (GBM, one antiserum, numb~r 1), the soluble frac-
tions of GBM extracted by treatment with sodium lauryl sul-
fate and cyanogen bromide (SLS-CnBr-GBM, three antisera, 
numbers 6, 12 and 13), the second and third DEAE-cellulose 
column chromatography peaks isolated from whole glomeruli 
solubilized with Genitron (trichlorotrifluoroethane) and 
trypsin (PGT-HuGl II, one antiserum, number 20B, and PGT-
HuGl III, two antisera, numbers 5 and 7), and the insoluble 
fraction isolated from trypsin treatment of GBM (GEM-trypsin 
resistant, one an·tiserum, number 14). Normal rabbit serum 
(NRS), a pool of serum samples taken from unimmunized rabbits, 
was used as control serum in all tests. 
B. Kidneys 
Human autopsy kidneys or white, albino mouse (Swiss 
, 
32 
outbred strain) kidneys were used in all experiments. Human 
kidneys were obtained from the morgues of Loyola University 
Medical Center, Maywood, Illinois, or from Hines Veterans 
Hospital, Hines, Illinois, from patients with non-renal dis-
eases. All the human kidneys used were pre-screened by light 
microscopy for glomerular abnormalities. Only kidneys with 
normal glomerular structures were used in subsequent isola-
tion procedures or fluorescent antibody tests. Kidneys thus 
obtained were either used immediately or stored at -Bo0 c for 
subsequent use. 
Mouse kidneys were obtained from a colony of mice 
maintained by the investigator. Kidneys were either used 
immediately upon removal or were frozen at -Bo0 c for later 
use. 
Adult human kidneys were those taken from patients 
greater than 1B years of age. Adult mouse kidneys were 
taken from mice greater than two months of age. Neonatal 
human kidneys were those taken from patients less than two 
months of age. Neonatal mouse kidneys were those taken from 
mice less than seven days of age. 
C. Kidney Sections 
Sections from adult and neonatal, human and mouse 
renal cortices were cut on an International Equipment Com-
pany (Needham Heights, Massachusetts) Cryostat. Approxi-
mately 2-3 mm square pieces of renal cortex were imbedded 
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in O.C.T. imbedding medium (Ames Company, Division Miles 
Laboratories, Inc., Elkhart, Indiana) and frozen on dry ice. 
Two micron thick sections were cut and placed on microscope 
slides, two sections per slide. Usually 100 slides were cut 
from each piece of renal cortex. They were fixed in acetone 
for 30 min. at 4°c, and washed three times, at 10 min. per 
wash, in 0.10 M sodium phosphate buffered saline (PBS), pH 
7.0. The sections were either used immediately in fluores-
cent antibody tests, or frozen and stored at -20°c for later 
use. 
D. Isolation of Renal Glomeruli and Glomerular Basement 
Membranes 
Glomeruli were isolated by the method of Greenspan 
and Krakower (29), The cortices were separated from the kid-
ney medullas with scissors. PBS washed pieces of cortex were 
then forced through steel wire mesh screening (F. P. Smith 
Wire Cloth Co., Franklin Park, Illinois) with a spatula into 
a container kept on ice. One hundred mesh screening was 
used for adult human kidneys, and 200 mesh for the remain-
der. Cold PBS was added to the filtrate, which was then 
centrifuged at 2000 rev/min. for 3 to 4 min. The super-
natant was poured off, and the sediment, which contained 
the glomeruli, was resuspended in cold PBS. Glomeruli were 
then washed and purified by a~lowing them to sediment, 3 to 
4 times in cold PBS, at 30 min. per wash. The purity of 
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the resultant suspensions were evaluated by light microscopy. 
If tubules or debris were present~ the suspensions were re-
washed in cold PBS until such materials were removed. Iso-
lates glomeruli were then washed with deionized water and 
either lyophilized or used for the isolation of GBM. 
GBM was isolated by the method of Krakower and Green-
spon (47), Glomerular suspensions were diluted in cold PBS 
to a final concentration of 10 percent w/v. They were then 
sonicated, at maximum intensity with a Branson sonifier, 
model S-75 (Branson Instruments Inc., Stamford, Connecticut) 
for six min., or until light microscopy showed that all glo-
meruli were disrupted. The sonicated material was centri-
fuged at 1800 rev/min. for 10 min., the resultant pellet 
representing glomerular basement membrane. GBM pellets were 
then washed twice in PBS and once in distilled water, and 
centrifuged at 1800 rev/min. for 10 min. after each wash. 
Isolated GBM was lyophilized and stored for further use. 
E. Isolation of Streptococcal Cell Membrane and Strepto-
coccal Cell Wall/Membrane Preparations. 
The isolation of group A, type 12 cell membranes was 
carried out by the method of Markowitz and Lange (67), 
Streptococci were grown in 10 liter lots in Todd-Hewitt 
broth at 37° Cina fermenter (Fermentation Design, Inc., 
Allentown, Pennsylvania). After 24 hour growth the orga-
nisms were heat-killed at 58° C for 1-2 hours, and centri-
fuged in a Sharples centrifuge. The 100 g of killed cells 
~ r: 
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were mechanically disrupted in a Gifford-Wood-Eppenbach Micro 
Mill, for one h at 4° C. Cell membranes were separated from 
cell walls by differential centrifugation in a Sorvall cen-
trifuge, with a continuous flow apparatus. The first two 
centrifugations were at 5000 rev/min. and 6000 r~v/min. res-
pectively, to remove cell walls. The solution was then cen-
trifuged a third time at 17,000 rev/min. to pellet cell mem-
branes. The cell membrane pellet thus obtained was washed 
several times with distilled· water, with continuous flow 
centrifugation at 17,000 rev/min. following each wash. The 
material was then lyophilized. Cell wall contamination of 
the lyophilized cell membrane preparation was measured by a 
quantitative rhamnose determination of the material. Cell 
membrane preparations with a rhamnose content of less than 
1.0 percent were considered free from significant cell wall 
contamination. 
Cell wall/membrane preparations of group A streptoco-
cci types 6, 22 and 25, used in absorption experiments, were 
produced by sonication of the organisms. Each organism was 
grown in one liter of Todd Hewitt broth, at 37° G for 24 h. 
After cultivation, the organisms were killed with phenol and 
heating for one h at 60° C, then centrifuged. The heat-
killed cells were sonicated, at maximum intensity, with a 
Branson model S-75 sonifier for 15 min. The resultant sus-
pensions were centrifuged at 2000 rev/min. for 20 min. The 
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supernatants were decanted and the pellets, which still con-
tained whole cells, were re-sonicated and centrifuged. The 
combined supernatants were then centrifuged at 20,000 rev/ 
min. for 30 min., the resultant pellets containing cell 
walls and membranes. They were then washed with deionized 
water and lyophilized. 
F. SCM and Glomerular Preparations Used for Absorption of 
Antisera. 
Materials used for absorption of antisera included 
whole human glomeruli, human GBM, purified type 12 SCM, and 
the insoluble precipitates, previously prepared (50), of 
type 12 SCM treated with lipase (SCM-Lipase), Triton X-100 
(SCM-Triton), chloroethanol (SCM-Cl-EtOH), trypsin (SCM-
Trypsin) and deoxycholate (SCM-DOC). Control preparations 
included homogenized (Ten Broeck grinder), washed and lyo-
philized human spleen and liver (obtained from autopsy), 
and the cell wall/membrane preparations of group A, M-types 
6, 22 and 25 streptococci. 
G. Carbohydrases 
The carbohydrase (CHOase) preparation (90), used to 
treat kidney sections and free from protease activity, was 
isolated from Streptococcus mutans, and was a gift of Dr. J. 
Hayashi, Department of Biochemistry, Presbyterian St. Luke's 
Medical Center, Chicago, Illinois. The lyophilized mixture 
consisted of the_ enzymes glucosidase, ~ -galactosidase, neu-
raminidase, fucosidase and hexosaminidase. Using serum q 1-
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glycoprotein as a standard, it was found to release 100% of 
the sialic acid, 100% fucose, 35% of the hexose and 25% of 
the hexosamines, in a six h period (T. Quish, unpublished 
observations). Similar measurements were made with human 
glomerular basement membrane (C. F. Lange, unpublished obser-
vations). 
H. Fluorescent Antibody Tests 
Fluorescent antibody tests were performed by an indi-
rect method (120) on two micron (u) thick sections of kid-
ney cortex. Two sections were evaluated per slide, one of 
which had been pretreated in a 0.2% solution of CHOase in 
PBS for 18 h. Following CHOase treatment the sections were 
washed three times in PBS, at 10 min. per wash. In each 
test, each antiserum was therefore evaluated in duplicate, 
once on an untreated section, and once on a duplicate CHOase 
treated section. 
In each test, kidney sections were first covered with 
a rabbit antiserum. They were incubated in a moist chamber 
at room temperature for 30 min., and then washed .three times 
in PBS, at 10 min. per wash. They were air dried and over-
layed with a 1:40 dilution of fluorescein-conjugated sheep 
anti-rabbit gamma globulin (previously prepared and titra-
ted), which had been absorbed with charcoal powder and either 
mouse or human lyophilized kidney homogenate. Following 
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another 30 min. incubation at room temperature in a moist 
chamber, they were washed as before, and mounted with cover-
slips in either 90% glycerol 10% PBS or in Permount (Fisher 
Scientific Co., Fair Lawn New Jersey) low fluorescence per-
manent mounting medium. The sections were then evaluated 
for glomerular fluorescent staining with a Leitz Wetzlar (E. 
Leitz, Inc., Rockleigh, New Jersey) fluorescence microscope. 
All of the glomeruli were observed in each section, and the 
fluorescent intensities graded on the-basis of total fluo-
rescence for all glomeruli. Intensities were given values 
of 0-4+, where O indicates a total lack of fluorescence, + 
any positive fluorescence along the GBM, and l+-4+ increas-
ing intensities of apple green fluorescence to a maximum 
(4+), where flecks of yellow fluorescence also appeared. 
Grading values were not standardized from test to test or 
day to day, nor could they be, owing to the lack of a photo-
meter apparatus on the microscope. Rather they were sub-
jective evaluations based on the memory and experience of 
the investigator. The effect of kidney section thickness on 
the fluorescent intensities was evaluated by testing single 
antisera on 1, 2, 3, 4 and 5 u thick sections. It was found 
that section thickness had no effect on observed fluorescent 
intensities, i.e., the fluorescent intensity for each anti-
serum tested remained stable regardless of section thickness. 
Controls for all tests included an evaluation of normal rab-
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bit serum and fluorescent antiserum alone, on 2 u thick sec-
tions of kidney cortex. If either of the controls were pos-
itive, the test was discarded and not recorded. Most tests 
were repeated at least once. Initially, the antisera were 
evaluated on a blind basis, the investigator not knowing the 
specificities of the antisera. The initial tests were also 
evaluated by a second investigator, also on a blind basis, 
and the results compared. Photographs, taken of each sec-
tion, were evaluated for comparison wLth the initial read-
ings. 
I. Antiserum Absorption Tests 
Anti-SCM or appropriate dilutions of anti-glomerular 
antisera were absorbed with the insoluble SCM, glomerular, 
or control preparations previously mentioned. Absorptions 
were carried out with either untreated or CHOase treated 
materials. For CHOase treatment, samples were first washed 
with saline and then placed in 2.0 ml of a 0.2% solution of 
CHOase, in PBS, in test tubes. The tubes were rotated for 
18 h at 37° C. After incubation, the samples were centri-
fuged at 2500 rev/min., the supernatants were frozen and 
stored, and the sediments were washed and used for antiserum 
absorption experiments. 
For the absorption tests 1.0 ml antiserum samples were 
added to approximately 10.0 mg of the untreated or CHOase 
treated SCM or g~omerular preparations, in test tubes. The 
, 
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test tubes were then incubated, with continuous rotation, for 
2 h at 37° C, and then overnight at 4° C. After incubation, 
the tubes were centrifuged at 2500 RPM for 20 min., and the 
supernatants were evaluated, in an indirect fluorescent anti-
body test, for residual antibody activity. The precipitates 
were frozen and stored for elution studies. 
J. Elution of Absorbed Antibodies 
Antibodies from absorption precipitates were eluted by 
the method of Campbell et al. (9). Precipitates were first 
washed three. times with saline, and centrifuged at 2500 rev/ 
min. for 15 min. after each wash. Elution was carried out 
by mixture with glycine-hydrochloride buffer, pH 3.0, stir-
ring for one hour at room temperature and overnight at 4° C. 
After centrifugation at 2500 rev/min. for 20 min., the super-
natant was poured off and tested for the presence of antibody 
activity by indirect immunofluorescence. The presence of 
gamma globulins in the eluate was assayed for by immunoelec-
trophoresis, using sheep anti-rabbit gamma globulin antiserum. 
Also, absorption precipitates were directly tested, both be-
fore and after elution, with fluorescein-conjugated sheep 
anti-rabbit gamma globulin, to note the appearance and dis-
appearance of bo~nd antibodies. 
K. Antiserum Titrations 
Anti-SCM antisera were titrated linearly in succes-
sive one-fold dilutions. 0.2 ml of each antiserum was 
added to 0.2 ml PBS (1:2), 0.4 ml PBS (l:J), 0.6 ml PBS (1:4), 
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o.8 ml PBS (1:5) etc. up to a 1:10 dilution. Each dilution 
was then tested, by indirect immunofluorescence, on dupli-
cate sections of human or mouse kidney cortex, one un-
treated and the other CHOase treated. 
Anti-glomerular antisera were titrated linearly in 
either successive 16-fold dilutions for tests on human kid-
ney or successive 4-fold dilutions for tests on mouse kid-
ney. Dilutions were made similar to those made for anti-SCM 
antisera, i.e., an amount of antiseru:m---(usually 0.1 ml) was 
added to the volume of PBS which produced the desired dilu-
tion. For the higher dilutions, 0.1 ml of a lower dilution 
was added to the volume PBS which produced the desired dilu-
tion - e.g., 0.1 ml of a 1/16 dilution added to 0.4 ml (1:90); 
added to 0.9 ml (1:160); added to 1.1 ml (1:192), etc. 
L. In Vivo Mouse Tests 
Anti-SCM or anti-GBM rabbit antisera were injected 
intraperitoneally, in 1.0 ml amounts in adult mice and in 0.2 
ml amounts in neonatal mice, to test for their localizing 
ability in the kidney glomeruli. All antisera had been pre-
viously absorbed repeatedly with mouse red blood cells (RBC) 
until they tested negatively in slide hemaglutination tests. 
Four hours after injection, the mice were sacrificed, 
and their kidneys, livers and lung tissue removed. The tis-
sues were embedded in O.C.T. embedding medium, and sectioned. 
Acetone-fixed se~tions were then treated with 1:40 dilution 
r 
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of fluorescein-conjugated sheep anti-rabbit gamma globulin, 
washed, mounted, and observed with the fluorescence micro-
scope for staining. 
M. Carbohydrate Analyses 
Qualitative carbohydrate analyses of GBM and SCM pre-
parations were carried out by chromatography on Whatman No. 
1 paper. Quantitative analyses were done using spectropho-
tometric techniques. 
All samples were prepared for chromatography by 3.0 N 
HCl hydrolysis, under reflux conditions, for 4 h. Hydrolyzed 
samples were passed over Amberlite MB-3 ion exchange columns, 
to collect neutral and amino sugars. Neutral sugars were 
eluted with distilled water, and amino sugars were eluted 
with 0.10 N HCl. Eluted fractions·were then flash-evaporated 
to dryness. For chromatography, samples were reconstituted 
with small (ul) amounts of water, and applied to Whatman No. 
1 paper, along with appropriate standards. Chromatography 
was carried out with either N-butanol, ethanol, water (4:5:1), 
for 42 h, or ethyl acetate, pyridine, water (10:4:3), for 16 
h. Chromatographs were developed with either 2% aniline 
oxalate (in ethanol) or 3% ammoniacal silver nitrate. 
For quantitative analyses, total hexoses were deter-
mined by the orcinol procedure of Rosewear and Smith (99), 
methyl pentoses by the cysteine-hydrochloride method of 
Dische and Shettles (18), sialic acids by the thiobarbitu-
ric acid procedur_e of Warren (119), and hexosamines by the 
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method of Winzler (123). Standard curves-were run with each 
determination. All samples were run in duplicate. 
N. Amino Acid Analyses 
Quantitative amino acid analyses of human and mouse 
GBM were performed with a Beckman model 120C amino acid 
analyzer. One milligram amounts of purified materials 
were hydrolyzed in vacuum-sealed test tubes in 1.0 ml of 
5.70 N constant boiling HCl, at 110° C for 22 h. After hy-
drolysis, the tubes were opened and the contents dried over 
sodium hydroxide in a vacuum dessicator. A 2.2 ml sample 
of 0.2 N citrate buffer, pH 2.2 was added to each tube, 
and duplicate 1.0 ml samples were placed on the short col-
umn and the long column, respectively. 
O. Enzymatic and Chemical Solubilization Procedures 
Type 12 streptococcal cell membranes were solubilized 
by either sodium lauryl sulfate, sodium lauryl sulfate and 
trypsin, or trypsin alone. Human glomerular basement mem-
branes were solubilized by either trypsin or collagenase. 
SLS solubilization of SCM was carried out by the addi-
tion of 1.0 g of SLS (Fisher Scientific Co., Fair Lawn, New 
Jersey) to 100 ml of a solution containing approximately 600 
mg of SCM in deionized water. One-hundred mg of sodium 
azide was added and the solution was stirred overnight at 
37° C. It was then centrifuged at 10, 0_00 rev /min. for 30 
min., and the supernatant was poured off and dialyzed for 
six days against running tap water, then two days against 
deionized water. The dialyzed ~elution was centrifuged 
again at 10,000 rev/min. for JO min., and the supernatant, 
representing solubilized SCM, was lyophilized. The pre-
cipitate was re-dissolved in deionized water, dialyzed 
again for six days against running tap water and two days 
against deionized water, centrifuged, and the supernatant, 
also representing solubilized SCM, lyophilized. 
Trypsinization of SCM, SLS-SCM or GBM was carried out 
essentially by the method of Markowitz___and Lange (67) in 
0.70 M sodium phosphate buffer, pH 8.1. Bovine pancreatic 
trypsin (Sigma Chemical Co., St. Louis, Missouri, 120,000 
units/mg) was added to a final 1.0% weight/weight concen-
tration, and the solutions were stirred for 6 h at J7° C, 
and then overnight at 4° C. Centrifugation at 20,000 rev/ 
min. for JO min. yielded a supernatant, representing solu-
bilized membranes, which was dialyzed for five days against 
deionized water, and lyophilized. Precipitates were re-
trypsinized in the same manner, and solubilized materials 
were added to the first extract. 
Collagenase digestion of human GBM was done by a met-
hod similar to that of Spiro (lOJ). Purified collagenase 
(type III from Clostridium histolyticum, Sigma Chemical Co., 
St. Louis Missouri, 400 units/mg) was added to a final 
weight/weight concentration of 10% to a solution of GBM in 
0.05 M tris-(hydroxymethyl)-aminomethane, hydrochloride (Tris-
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HCl) buffer, pH 7,5, containing 0.01 M CaC12 . The solution 
was stirred for 72 h at 37° C, with collagenase added to a 
final weight/weight concentration of 0.5% at 24 and 48 h. 
After digestion, the solution was centrifuged at 10,000 rev/ 
min. for 30 min., and the supernatant was dialyzed against 
deionized water for 5 days (4° C), and lyophilized. 
P. Fractionation of Solubilized Membranes by DEAE-Cellu-
lose Column Chromatography 
DEAE-cellulose (Eastman Organic-Chemicals, Rochester, 
New York) was first regenerated by alternate 30 min. wash-
ings with 0.1 N NaOH, deionized water, O.l N HCl, and deio-
nized water, the process being repeated three times, with a 
final wash in 0.1 N NaOH. A one gram sample of the washed, 
regenerated material was then titrated by first mixing it 
with 0.5 M NaCl for 30 min. followed by filtration on a 
Buchner funnel. The dryed filtrate (pH 9,7) was titrated 
to pH 3.0 with 0.1 N HCl, the final volume of HCl being 
used to calculate the exchange capacity of the resin. DEAE-
cellulose was stored in 0.05 M phosphate buffer, pH 7.8, at 
4° c. 
Fractionation of SLS-SCM, SLS-SCM trypsin, and GBM-
trypsin was carried out in lxl5 cm columns, with a 10 ml bed 
volume of DEAE-cellulose, with an exchange capacity of ap-
proximately 200 mg protein. The DEAE cellulose was first 
equilibrated in five times the volume of 0.005 M sodium 
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phosphate buffer, pH 7.8, by repeated 30 111in. mixings and 
filtration to dryness. After a 2 h stirring in 0.005 M 
phosphate buffer, pH 7.8, columns were poured, and further 
equilibrated by passing twenty times volume (200 ml) buffer 
through the columns. 
Samples to be chromatographed (50-100 mg) were dis-
solved in equilibration buffer in 2.0 ml amounts and applied 
to columns. Fractions were collected in 5 ml amounts with a 
Fractomat (Buchler Company, Fort Lee, -New Jersey) automatic 
fraction collecter. Elutions were carried out with sodium 
phosphate buffers of increasing molarities and decreasing 
pH I s : 0. 00 5 M , pH 7 . 8 I 0 . 01 MI pH 6 . 1 I 0 . 2 M I pH 7 . 0 I 0 . 4 M I 
pH 6.o, o.6 M, pH 5.0, 0.1 r!J., pH 5.0, 0.3 M, pH 4.o, 0.3 M 
phosphate, 0.2 M NaCl, pH 3.5, and 0.3 M phosphate, o.4 M 
NaCl, pH 3.5. Fractions were scanned at 280 nm with record-
ing on a Gilson recorder. Peaks were collected, dialyzed 
against deionized water for three days, and lyophilized. 
Q. Immunodiffusion and Immunoelectrophoresis 
Immunodiffusion with solubilized GBM and SCM was car-
ried out by the double diffusion procedure of Ouchterlony 
(84), in one percent Ionagar gels (Colab, Chicago Heights, 
Illinois) on glass slides. After antiserum addition, the 
slides were incubated for 38 h in a moist chamber at room 
temperature. The slides were then washed, two days in saline 
and two days in deionized water, and stained with Napthalene 
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Black 12B (Allied Chemical and Dye Corporation, New York, 
New York) in methanol, glacial acetic acid and water (5:2:5). 
Destaining was carried out with methanol, glacial acetic acid 
and water (7:1:2). 
Immunoelectrophoresis, in the antibody elution experi-
ments, was performed with 1.5 percent Ionagar gels with a 
Gelman (Gelman Instrument Co., Ann Arbor, Michigan) immuno-
electrophoresis apparatus. Electrophoresis of antigenic 
materials was allowed for 100 min. at_JO mA and 100 volts in 
0.10 M barbital buffer, pH 8.6. The immunodiffusion phase 
was the same as that described for Ouchterlony gels, as was 
the washing, staining and destaining procedures. 
Antigen concentrations, for all tests, ranged from 3.0 
mg/ml to 20 mg/ml. All antisera were used undiluted. 
R. Polyacrylamide Gel Electrophoresis (PAGE) 
Polyacrylamide gel electrophoresis, of GBM and SCM pre-
parations and DEAE fractions, was carried out by the disc 
method of Davis and Ornstein (12). Gels were run at pH 8.3 
with Tris-glycine buffer, at 100 volts, 40 mA (or about 6 mA/ 
gel) for approximately one h_or until the brom-phenol blue 
tracking dye reached the bottom of the gel. Amounts of mate-
rial applied to each gel ranged from 200-400 ug. 
The lower, or running gel was a 7.5% acrylamide gel. 
The stock solutions used to make the running gels were as 
follows: Solution A - 48 ml 1.0 N HCl, 36.3 g Tris buffer, 
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o.46 ml N:N:N:N-tetramethyl-1:2-diamino-ethane (TEMED) 
(Eastman Organic Chemicals, Rochester, New York), and water 
to 100 ml, pH 8.9; Solution C - 30.0 g of acrylamide (East-
man Kodak Co., Rochester, New York) 0.8 g of methylene-bis-
acrylamide (Eastman Kodak Co. , Rochester, New York), 0. 015 g 
of potassium ferricyanide and water to 100 ml; Solution F -
70 mg of ammonium persulfate (Fisher Scientific Co., Fair 
Lawn, New Jersey) in 50 ml of deionized water, prepared 
fresh daily. For all preparations, 2 parts of solution A 
were mixed with 4 parts of solution C and 2 parts of water. 
Five parts of the mixture were then mixed with 5 parts of 
solution F. The resultant mixture was then pipetted into 
open ended glass tubes, 65 mm long, inner diameter 6 mm, 
in a holder. The running gel solution was brought up to 
within 25 mm of the top of the tube. Deionized water was 
carefully layered over the top of the solution, and poly-
merization was allowed for 30 min. The water layer was then 
removed. 
The middle, or stacking gel was a 3 percent acrylamide 
gel. The stock solutions used to make the stacking gel were 
as follows: Solution B - 48 ml 1.0 N HCl, 5.98 gms Tris 
buffer, 0.46 ml TEMED, and water to 100 ml, pH 6.7; Solu-
tion D - 10 grams acrylamide, 2.5 grams methylene-bis-
acryiamide and water to 100 ml; Solution E - 4.o mg ribo-
flavin in 100 ml,H2o. For gel preparation, one part solu-
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tion B was mixed with 2 parts solution D, 1 part solution E, 
and 4 parts water. The mixture was covered with aluminum 
foil to prevent light from causing polymerization. The mix-
ture was pipetted on top of the running gel to within about 
1/4 inch of the top of the tube. Deionized water was care-
fully layered on top, and the gel tubes were placed approxi-
mately J inches from a fluorescent light source, for 20 min., 
to polymerize. 
The sample gel was the·same as the stacking gel, ex-
cept that 200-400 ug of the material to be run was mixed with 
it. It was layered on top of the stacking gel, to the top of 
the tube, and allowed to polymerize. 
After each run, the gels were removed from the tubes 
and stained with either 1% Buffalo black (Allied Chemical, 
Morristown, New Jersey) in 7% acetic acid (destaining with 
65% H20, 25% ethanol, 10% acetic acid) or with 0.05% Coomasie 
Blue (Bio-Rad Laboratories, Richmond, California) in 20% tri-
chloroacetic acid (TCA) (Mallinckrodt Chemical Works, St. 
Louis, Missouri) destaining with 12.5% TCA. All gels were 
stored in 7% acetic acid. All materials were run in dupli-
cate. 
S. Photography 
a. Fluorescent antibody tests. Color slides or black 
and white negatives were taken' of all fluorescent antibody 
tests. Color slides were taken with either 35 mm GAF 500 
(GAF Corporation, New York, New York) color slide film, ASA 
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500, at 30 second exposure times, or with 35 mm Kodachrome 
II (Eastman Kodak Co., Rochester, New York) color slide 
film, ASA 40, at 2 min. exposure times. All photographs 
were taken with a Leica (Ernst Leitz, Wetzlar, Germany) 
camera, mounted on the Leitz fluorescent microscope. Color 
slides were processed commercially (Holiday Camera Co., 
Broadview, Illinois). 
Black and white negatives were taken with 35 mm Tri-X 
Pan film (Eastman Kodak Co., Rochester_,_ New York), ASA 400, 
at 35 second exposure times, with the-Leica camera. The 
negatives were developed with either D-76 or Microdol-X. 
(Eastman Kodak Co., Rochester, New York) developer. Prints 
were made on Kodabromide (Eastman Kodak Co., Rochester, New 
York) paper, of either F-3, F-4 or F-5 weights. Black and 
white negatives were also taken of color prints which had 
been mounted on cardboard (see Fig. 2 and 3). The nega-
tives and prints were developed in the same manner. 
b. Immunodiffusion photographs. Photographs of im-
munodiffusion plates were taken with a Pentax/Asahi camera 
with black and white Tri-X Pan film, at F-stop 2.0 and 1/15 
second exposure time. The negatives were developed and 
printed as above. 
CHAPTER III 
RESULTS 
A. Fluorescent Antibody Tests 
Indirect fluorescent antibody (FAb) tests were graded, 
independently by two individuals, on a scale of 0-4+, for 
intensity of glomerular fluorescence, and either as linear 
(L) or granular (G), based on the type of pattern noted along 
the GBM. Fig. 1 shows representative photographs of glome-
rular staining intensities graded 0, ±' l+, 2+, 3+ and 4+. 
Fig. 2 shows examples of linear and granular fluorescent 
staining patterns. Evaluations of the effect of kidney sec-
tion thickness on fluorescent intensities revealed that re-
gardless of thickness, ·intensities remained stable. 
1. Screening of anti-SCM and anti-glomerular antisera on 
normal adult mouse and human renal cortex sections. All 32 
antisera, and normal rabbit serum, were initially screened 
for glomerular staining capacity on sections of mouse kidney 
(NMK) which had been untreated or pretreated with 0.2% CHOase. 
Kidneys from several mice were screened with all antisera. 
The results are presented in Tables 1 and 2, along with an 
evaluation of the patterns (granular or linear) seen. Only 
five of the anti-SCM antisera (numbers 2, 4, 9, 15 and 19) 
showed appreciable cross-reactivity with mouse GBM. Patterns 
observed were generally granular in nature. 
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Fig. 1. Glomerular fluorescent staining 
intensities on adult human kidney #1 (NHK-1). 
O= #18 anti-CnBr-SCM; ± = #19B anti-SLS-CnBr-
SCM; 1+ = #4 anti-SLS-SCM; 2+ = #11 anti-
whole gloms; J+ = #20 anti-PGT-HuGl II; 4+ = 
#8 anti-whole gloms. Intensities were graded 
according to degree (deepness) and brightness 
of apple green color. See tables 3 and 4 and 
Materials and Methods. 
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Fig. 2. Glomerular fluorescent staining pat-
terns. Top: anti-SLS-SCM II, #28, vs. adult normal 
human kidney (#1), showing granular (G) fluorescence; 
Bottom: anti-PGT-HuGl II, #20, vs. adult normal human 
kidney (#1), showing linear (L'.}. fluorescence. 
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TABLE 1. Indirect fluorescent antibody tests (intensities and staining patterns) 
of 22 anti-SCM antisera vs. normal mouse kidney sections, before and 
after CHOase treatment. 
NMK-1 NMK-2 
e i:: i:: i:: H H H 
Q) Q) Q) Q) 
+' CHOase +' +' CHOase +' +' +' +' +' 
ANTISERUM Untreated ~ Treated Ill Untreated Ill Treated Ill ~ntreated A.. A.. A.. 
16. Anti-SCM 0 0 0 0 0 
19A. Anti-SCM 0 0 0 ± G ND 
20A. Anti-SCM 0-± G 0-± G 0 0 ND 
23. Anti-SCM 0 0 0 0 ND 
25. ,,A'nti-SCM 0 0 0 0 ND 
29. Anti-SCM 0 0 0 0 NP 
37. Anti-SCM 0 0 0 0 ND 
2. Anti-SLS-SCM ± G ± G ± L ± L ± 
4. Anti-SLS-SCM 2+ G 1-2+ G 1+ G 1+ G 0 
10. Anti-SLS-SCM 0-± G 0-± G ± G ± G 0 
17. Anti-SLS-SCM 0 0-± G 0 0-± G 0 
9. Anti-SLS-CnBr-SCM 1+ G 1+ G 1+ 1-2+ G ±-1+ 
19B. Anti-SLS-CnBr-SCM 0-± G 0-± G 0 ±-1+ G 0-± 
21. Anti-SLS-CnBr-SCM 0 0 0 0 ND 
27. Anti-SLS-CnBr-SCM 0 0 0 0 ND 
22. Anti-SLS-SCM II 0 0 0 0 ND 
28. Anti-SLS-SCM II 0 0 0 0 ND 
3. Anti-pepsin-CnBr-SCM 0 0-± G ± G ± G 0 
15. Anti-pepsin-CnBr-SCM 0-± G 1+ G ± G ± G 0 
18. Anti-CnBr-SCM 0-± G ±-1+ G 0 0-± G 0 
24. Anti-ueosin-SCM 0 0 0 0 ND 
30. Anti-pepsin-SCM 0 0 0 0 ND 
NRS 0 0 0 0 0 
FAb alone 0 0 0 0 0 
ND = not done; G = granular; L = linear 
NMK-3 
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ANTISERUM 
1. Anti-GBM 
8. Anti-whole gloms 
11. Anti-whole gloms 
5. Anti-PGT-HuGl III 
7. Anti-PGT-HuGl III 
6. Anti-SLS-CnBr-GBM 
12. Anti-SLS-CnBr-GBM 
13. Anti-SLS-CnBr-GBM 
14. Anti-GBM-trypsin 
resistant 
20B. Anti-PGT-HuGl II 
NRS 
FAb alone 
TABLE 2. Indirect fluorescent antibody tests (intensities and staining patterns) 
of 10 anti-glomerular antisera vs. normal mouse kidney sections, before 
and after CHOase treatment. 
NMK-1 NMK-2 NMK-3 NMK-:4 
~ ~ ~ ~ 
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1+ G 1+ G 2+ L 1+ G 1+ L 2+ L 1+ G 1-2+ 
± G 2+ L ± L 1+ G ± L + L ND ND 
-
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ND = not done; NG = no glomeruli on section; G = granular; L = linear 
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All 10 of the anti-human glomerular.antisera reacted, 
with varying intensities and patterns, with mouse GBM (Table 
2). 
With both sets of antisera, sections from different kid-
neys showed varying degrees of reactivity - that is, each anti-
serum did not react uniformly with each kidney, indicating that 
different kidneys vary in antigenic specificity. Also, fol-
lowing carbohydrase treatment, kidney sections sometimes 
showed an increased reactivity, as measured by fluorescence 
intensity, with a few of the antisera· (e.g., numbers 7 and 14, 
Table 2). Thus, of the 54 individual tests in Table 1, 5 
showed greater fluorescence after CHOase treatment than before 
treatment (where fluorescence increase is defined as at least 
a one-unit increase in staining intensity, e.g., 0-+, l+-2+, 
3+-4+, etc.). The remaining 49 tests showed either less than 
a one unit increase or no increase at all. In Table 2, of 35 
individual tests with glomerular antisera, 12 showed increased 
fluorescence intensities due to CHOase treatment, 2 tests 
showed a decreased fluorescence (antisera numbers 12 and 13, 
NMK-2), and the rest showed either less than a one unit in-
crease or no increase at all. 
The 32 antisera were similarly screened for reactivity 
against sections of adult human kidney cortex (NHK). Again, 
sections from several different human autopsy kidneys were 
used. The resul~s, presented in Tables 3 and 4, are tests 
/ 
TABLE 3. Indirect fluorescent antibody tests (intensity and staining patterns) 
of 22 anti-streptococcal cell membrane antisera vs. normal human kidney 
sections, before and after CHOase treatment. 
NHK-1 NHK-2 
i::: f f ~ ~ GI 
" +' CHOase +' +' CHOase +' +' +' +' +' 
ANTISERUM Untreated ~ Treated f1j Untreated f1j Treated if Untreated p.. p.. 
16. Anti-SCM ± G 1+ G ND ND ND 
19A. Anti-SCM ± G ± G 0-± G ± G ± 
20A. Anti SCM 1+ G 2+ G ±-1+ .G 1-2+ G 1+ 
23. Anti-SCM 1+ G 2-3+ G 1+ G 1-2+ G 1+ 
25. Anti-SCH 0-1+ G 1+ G 1+ G 1-2+ G 1+ 
29. Anti-SCM 1+ G 1+ G 1+ G 1-2+ G 1+ 
37. Anti-SCM 0 ± G 0 ± G ± 
2. Anti-SLS-SCM ± G 1+ G ND ND ND 
4. Anti-SLS-SCM 1+ G 1+ G 1+ G l+ G ND 
10. Anti-SLS-SCM 1+ L 2+ G ND ND ND 
17. Anti-SLS-SCM 0 ± G ND ND ND 
9. Anti-SLS-CnBr-SCM ± G 1+ G ± G 1-2+ G ND 
19B. Anti-SLS-CnBr-SCM ± G ± G ND ND ND 
21. Anti-SLS-CnBr-SCM 1+ G 1-2+ G 1+ G 2+ G 2+ 
27. Anti-SLS-CnBr-SCM ± G 1-2+ G 1+ G 1+ G ± 
22. Anti-SLS-SCM II 1+ G 1+ G ± G ± G 1+ 
28. Anti-SLS-SCM II 1+ L 2-3+ L 1+ G 2+ G ± 
3. Anti-pepsin-CnBr-SCM 1+ G 1+ G 1+ G 1+ G ND 
15. Anti-pepsin-CnBr-SCM 1+ G 1+ G ND ND ND 
18. Anti-CnBr-SCM 0 0 ND ND ND 
24. Anti-pepsin-SCH ± G 1+ G 1+ G 1+ G 0 
30. Anti-pepsin-SCH 1+ G 1+ G 0 0 0 
NRS 0 0 0 0 0 
FAb alone 0 0 0 0 0 
ND = not done; G = granular; L = linear 
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TABLE 4. Indirect fluorescent antibody tests (intensity and staining patterns) 
of 10 anti-glomerular antisera vs. normal human kidney sections, 
before and after CHOase treatment. 
NHK-1 NHK-2 
CHOase CHOase 
ANTISERUM Untreated Pattern Treated Pattern Untreated Pattern Treated 
Anti-GBM 3+ L 3+ L ND ND 
Anti-whole gloms 4+ L 4+ L 4+ L 4+ 
Anti-whole gloms 2+ L 2+ L 2+ L 2+ 
Anti-PGT-HuGl III 2+ L 2-3+ L 2-3+ L 3-4+ 
Anti-PGT-HuGl III 3+ L 4+ L ND ND 
Anti-SLS-CnBr-GBM 3+ L 4+ L ND ND 
Anti-SLS-CnBr-GBM 2+ L 3+ L ND ND 
Anti-SLS-CnBr-GBM 3+ L 4+ L ND ND 
Anti-GBM-trypsin 1-2+ G 2+ G 1-2+ G 2+ 
resistant 
20B. Anti-PGT-HuGl II 3+ L 3-4+ L 3+ L 3-4+ 
NRS 0 0 0 0 
FAb alone 0 0 0 0 
ND = not done; G = granular; L = linear 
Pattern 
L 
L 
L 
L 
L 
\Ji. 
CP 
.. __, 
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on sections from those kidneys which reacted most positively, 
since not all kidneys tested showed reactivity with the SCM 
antisera. Eighteen of the 22 anti-SCM antisera showed ap-
preciable cross-reactivity with human GBM (Table 3). Again 
the staining patterns were almost uniformly granular, and 
all 10 of the glomerular antisera were reactive with human 
kidney GBM (Table 4), with almost uniformly linear staining 
patterns. CHOase pretreatment of the kidney sections was 
clearly seen to have a potentiating effect on their reacti-
vity with several of the antisera (e.g., numbers 10, 20A, 23 
and 28, Table 3). Thus of 49 individual tests with anti-SCM 
antisera (Table 3), 23 showed at least a one unit increase 
in staining intensity, and the remainder showed either less 
than a one unit increase or no increase at all. Of the 15 
individual tests with anti-glomerular antisera (Table 4), 5 
showed an increase in fluorescence due to CHOase treatment 
and the other 10 no increase. Representative photographs of 
this potentiating effect are presented in Fig. 3. 
2. Fluorescent antibody titrations of Anti-SCM and anti-
glomerular antisera. Two highly reactive anti-SCM antisera 
and two highly reactive anti-glomerular antisera were lin-
early titrated, ~ith p~sphate buffered saline, and each 
silution was tested on untreated and CHOase treated NHK, to 
quantitate the potentiating (or unmasking) effect of CHOase 
treatment. The antiserum titers, along with their undiluted 
staining intensities, are presented in Table 5. 
"' 
Fig. 3. Potentiating effect of CHOase treatment on fluorescent 
intensities. Sections at right (A= after) were ~retreated with a 0.2% 
solution of CHOase overnight. Sections at left (B= before) were un-
treated. Top: Anti- PGT-HuGl III #7 vs. NHK-1. B= 3+, A= 4+. 
Bottom: Anti-SCM #23 vs. NHK~1. B= 1+, A= 2-3+. °' 0 
TABLE 5. Undiluted glomerular staining intensities and titers of 
anti-glomerular and anti-streptococcal cell membrane 
antisera vs. untreated and CHOase treated normal human 
kidney sections. 
vs. CHOase 
vs. Untreated NHK-4 Treated NHK-4 
Undiluted Undiluted 
61 
Antiserum Intensity Titera Intensity Titer 
23. Anti-SCM 2+ 1/3b 3+ 1/6 
28. Anti-SLS-SCM II 2+ 1/4b 3+ 1/7 
8. Anti-whole 4+ 1/128c 4+ 1/192 glomeruli 
20B. Anti-PGT- 3+ 1/128c 4+ 1/160 HuGl II 
a Titers represent the highest dilution still showing ± GBM fluores-
cence. 
b Linear 1-fold dilutions. 
c Linear 16-fold dilutions. 
\ 
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The titers of all four antisera were found to be in-
creased when tested on CHOase treated NHK sections as corn-
pared to untreated sections. Anti-SCM titers were much lower 
against human GBM than were anti-glornerular antiserum titers, 
even when their undiluted staining intensities were the same. 
3. Absorption of anti-SCM and anti-glomerular antisera with 
purified human GBM. Two antisera, an anti-SCM and an anti-
whole glorneruli antiserum, were absorbed with isolated human 
GBM, either untreated or pretreated with 0.2% CHOase (8.0 mg 
GBM/ml antiserum)~ Absorption supernatants were then tested 
to determine their staining intensities in indirect FAb 
tests against NHK. The results are presented in Table 6. 
Carbohydrase treated GBM was found to be a much better ab-
sorbing preparation, with both homologous and heterologous 
antisera. Complete absorption of antibody cross-reactivity 
was found when anti-SCM antiserum was absorbed with CHOase 
treated GBM, while only partial absorption was seen with un-
treated GBM. 
4. Elution of bound antibodies from absorption precipitates. 
Attempts made to elute the bou~d antibody from the absorp-
tion precipitate~ met with only partial success. Irnrnunoelec-
trophoresis of the pH 3.0 eluate (brought back to pH 7.0 
with 0.1 N NaOH) from the anti-SCM-CHOase treated GBM preci-
pitate did not reveal the presence of gamma globulins, when 
it was tested with either goat anti-rabbit whole serum or 
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TABLE 6. Indirect fluorescent antibody tests of #23 anti-
streptococcal cell membrane antiserum and #8 anti-
23. 
23. 
8. 
8. 
whole glomeruli antiserum absorbed with human glomerular 
basement membrane before and after CHOase treatment vs. 
normal human kidney sections. 
Absorbing Antigen 
Untreated GBM CHOase Treated GBM 
Untreated CHOase Untreated CHOase 
Antiserum NHK-1 NHK-1 NHK-1 NHK-1 
Absorbed 
± ±-1+ 0 0 anti-SCM 
Unabsorbed 1+ 2-3+ 1+ 2+ 
anti-SCM 
Absorbed 2+ 
anti-glomeruli 2-3+ ± 1+ 
Unabsorbed 4+ 4+ 4+ 4+ anti-glomeruli 
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goat anti-rabbit gamma globulin. Nor did the eluate give a 
positive indirect fluorescent antibody test when tested 
against NHK. However, when the absorption precipitate, both 
before and after elution attempts, was fixed on glass slides 
and treated with fluorescein-conjugated goat anti-rabbit 
gamma globulin, the GBM stained brightly. GBM which had not 
been used for absorption, and GBM used to absorb normal rab-
bit serum, which was fixed and stained in the same manner, 
failed to fluoresce. 
Elution of homologous antibodies was completely suc-
cessful. The pH 3.0 eluate of the anti-whole glomeruli-
CHOase treated GBM absorption precipitate revealed the pre-
sence of gamma globulins in immunoelectrophoresis with either 
goat anti-whole rabbit serum or goat anti-rabbit gamma globu-
lin antisera. In addition, the neutralized eluate gave 
positive (2+) fluorescence when tested against NHK in in-
direct immunofluorescence tests. Also, the absorption pre-
cipitate, when fixed and treated with fluorescent antibody, 
stained positively before elution, and did not stain follow-
ing elution. 
5. Absorption of anti-SCM and anti-glomerular antisera with 
various SCM, glomerular and control preparations. Six in-
soluble SCM and two glomerular preparations were chosen for 
use in reciprocal cross-absorption tests with anti-SCM and 
anti-glomerular antisera. Absorptions were carried out in 
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duplicate (10 mg/ml antiserum) with the absorbant either un-
treated or pretreated with CHOase. Absorption supernatants 
were tested in immunofluorescent tests against CHOase treated 
or untreated NHK. Control preparations were treated iden-
tically to that of the test preparations. Anti-SCM antisera 
were absorbed undiluted, while anti-glomerular antisera were 
first diluted 1:J2 before being absorbed. The 1:J2 dilutions 
of the anti-glomerular antisera gave 2-J+ fluorescent inten-
sities, comparable to that of the undiluted anti-SCM anti-
sera. The results are presented in Tables 7-10. 
SCM preparations which were not treated with CHOase 
had little antibody absorbing activity for the anti-glomeru-
lar antisera (Tables 7 and 8). However, following their 
treatment with CHOase, absorbing activity became evident, 
especially with the SCM-trypsin insoluble membrane prepara-
tion. SCM-triton and SCM-DOC had little absorbing activity, 
even after CHOase treatment. Liver, spleen and the cell wall-
membrane (CW-M) preparations of the three non-nephritogenic 
group A streptococci showed no absorbing activity. In the 
homologous absorptions, GBM or whole glomeruli preparations, 
even untreated, completely absorbed out the antibody activ-
ity of the diluted antisera. 
In the reciprocal tests (Tables 9 and 10) similar re-
sults were found. GBM and whole glomeruli, untreated, only 
partially absorbed out the cross-reactive antibodies in anti-
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TABLE 7. Effect of absorption of #8 anti-whole glomeruli antiserum with various 
insoluble SCM, glomerular and control.preparations (untreated and 
CHOase treated) vs. untreated and CHOase treated NHK. 
#8 1/32 Dilution #8 1/32 Dilution 
Absorbed with Absorbed with CHOase 
Untreated Arz. Treated Ag 
Absorbing Antigen Untreated NHK CHOase NHK Untreated NHK CHOase 
SCM ± 1+ ± 1+ 
SCM-lipase ± 1+ ± ±-1+ 
SCM-triton 1-2+ 1-2+ 1+ 1-2+ 
SCM-Cl-EtOH 1-2+ 2+ ± 1+ 
SCM-trypsin 1+ 1-2+ ± 1+ 
SCM-DOC 1+ 1+ 1+ 2+ 
GBM 0 0 0 0 
Whole glomeruli 0 0 0 0 
. 
Liver homogenate 2+ 2+ 2+ 2-3+ 
Spleen homogenate 1-2+ 1-2+ 2+ 2+ 
CW-M T-25 2+ 2+ 2+ 3+ 
CW-M T-22 2+ 2-3+ 2+ 2+ 
CW-M T-6 2+ 2-3+ 2+ 2+ 
NHK 
Unabsorbed antiserum 2-3+ 2-3+ 2-3+ 2-3+ 
NRS 0 0 0 0 
FAb alone 0 0 0 0 
r 
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TABLE 8. Effect of absorption of #20 anti-PGT-HuGl II antiserum with various 
insoluble SCM, glomerular and control preparations (untreated and 
CHOase treated) vs. untreated and CHOase treated NHK. 
#20B 1/32 Dilution #20B 1/32 Dilution 
Absorbed with Absorbed with CHOase 
Untreated Ag Treated Ag 
Absorbing Antigen Untreated NHK CHOase NHK Untreated NHK CHOase 
SCM 1+ 2+ ± ± 
SCM-lipase 2+ 2+ ± 1+ 
SCM-triton 2+ 2+ 1+ 1+ 
SCM-Cl-EtOH 2+ 2+ 1+ 1+ 
SCM-trypsin 1+ 1+ 0 0 
SCM-DOC 2+ 2+ 2+ 2+ 
GBM 0 0 0 0 
Whole glomeruli 0 0 0 0 
Liver homogenate 2+ 2+ 2+ 2-3+ 
Spleen homogenate 2+ 2+ 1-2+ 2-3+ 
CW-M T-25 2-3+ 2-3+ 2-3+ 2-3+ 
CW-M T-22 2+ 2+ 2+ 2-3+ 
CW-M T-6 2+ 2-3+ 2+ 2+ 
Unabsorbed antiserum 2+ 2+ 2+ 2+ 
NRS 0 0 0 0 
FAb alone 0 0 0 0 
NHK 
r 
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TABLE 9. Effect of absorption of #23 anti-SCH antiserwn with various insoluble 
SCH, glomerular and control preparations (untreated and CHOase 
treated) vs. untreated and CHOase treated NHK. 
Undilute #23 Undilute #23 
Absorbed with Absorbed with CHOase 
Untreated Ag Treated Ag 
Absorbing Antigen Untreated NHK CHOase NHK Untreated NHK CHOase NHK 
SCH ± 1+ 0 0 
SCH-lipase 1+ 1-2+ ± 0 
SCH-triton 1+ 1+ 1+ 1+ 
SCH-Cl-EtOH 1-2+ 1-2+ ± ± 
SCH-trypsin ± ± 0 ± 
SCM-DOC 1-2+ 2+ 0 0 
GBH ± ± 0 0 
Whole glomeruli ± ± 0 0 
Liver homogenate 2+ 2+ 1-2+ 2+ 
Spleen homogenate 2+ 2+ 1-2+ 2+ 
CW-H T-25 1-2+ 2+ 1-2+ 2+ 
CW-H T-22 1-2+ 1-2+ 1-2+ 1-2+ 
CW-M T-6 1-2+ 2+ 1+ 1+ 
Unabsorbed antiserwn 1-2+ 2-3+ 1-2+ 2-3+ 
NRS 0 0 0 0 
FAb alone 0 0 0 0 
TABLE 10. Effect of absorption of #28 anti-SLS-SCM II antiserum with various 
insoluble SCM, glomerular and control preparations (untreated and 
CHOase treated) vs. untreated and CHOase treated NHK. 
Undilute #28 Undilute #28 
Absorbed with Absorbed with CHOase 
Untreated Ag Treated Ag 
Absorbing Antigen Untreated NHK CHOase NHK Untreated NHK CHOase NHK 
SCM ± 2+ 0 1+ 
SCM-lipase 1+ 2+ ± ± 
SCM-triton ± 1-2+ ± 1+ 
SCM-Cl-EtOH ± 1+ ± 1+ 
SCM-trypsin 1+ 2+ 0 1+ 
SCM-DOC 1+ 2+ 0 ± 
GBM 1+ 2+ 0 ± 
Whole glomeruli 1+ 2+ ± ± 
Liver homogenate 1-2+ 2+ 2+ 2+ 
Spleen homogenate 1-2+ 2+ 2+ 2+ 
CW-M T-25 1-2+ 2+ 1-2+ 2+ 
CW-M T-22 1+ 2+ 1+ 2-3+ 
CW-M T-6 2+ 2+ 1+ 2+ 
Unabsorbed antiserum 1-2+ 2-3+ 1-2+ 2-3+ 
NRS 0 0 0 0 
FAb alone 0 0 0 0 
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SCM antisera. However, after their treatment with carbohy-
drase, the preparations had markedly increased absorbing 
capacities. Even in homologous tests, CHOase pretreatment 
of SCM absorbing preparations markedly increased their capa-
cities to absorb cross-reactive anti-SCM antibodies. Again, 
the control preparations showed little or no absorbing 
activity. 
The results of the reciprocal cross absorption tests 
indicate that cross-reacting antigens-on both SCM and GBM 
may be masked by carbohydrate units. 
6. Carbohydrate analyses, and percent hexose released by 
CHOase, of SCM and glomerular absorption preparations. The 
sugar content of SCM and glomerular preparations used in the 
absorption experiments were evaluated by paper chromatography 
and/or spectrophotometry. Total hexoses were quantitatively 
determined for each preparation, and the amounts of hexoses 
released by CHOase treatment were measured by using the 
supernatants of CHOase treated materials. The results are 
presented in Table 11. 
Glucose was present in· all SCM samples. Galactose, 
rhamnose and glucosamine were also found, in whole SCM, SCM-
lipase and SCM-tritori, respectively. CHOase was found to 
release between 10 and 20 percent of the total hexoses found 
in each preparation. Quantitative measurements for other 
sugars were not made. 
TABLE 11. Types of carbohydrates identified, total hexose concen-
tration, and amount of hexose released by carbohydrase 
treatment or SCM and glomerular antigens used for 
absorption of antisera. 
Absorbing Antigen 
SCM 
SCM-lipase 
SCM-triton 
SCM-Cl-EtOH 
SCM-trypsin 
SCM-DOC 
GBM 
Whole Glomeruli 
Carbohydrates 
Identifieda 
Glucose 
Galactose 
Glucose 
Rhamnose 
Glucose 
Galactosamine 
Glucose 
Glucose 
Glucose 
Glucose 
Galactose 
Mannose 
Hexosamines 
Fucose 
Sialic Acid 
Glucose 
Galactose 
Mannose 
Fucose 
Sialic Acid 
Hexosamines 
Percent 
Total 
Hexose 
a.sb 
7 .ab 
Percent 
Hexose 
Released 
19.7 
11.0 
10.2 
19.3 
15.0 
14.4 
13.1 
21.2 
a Identified by paper chromatography and/or spectrophotometric 
procedures. 
b Determined using a glucose standard. 
c Determined using·a galactose:glucose:mannose, 2:1:1 standard. 
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7. Carbohydrate masking in neonatal GBM.· Since it seemed 
evident that carbohydrate groups masked antigenic cross-
reacti ve sites between SCM and GBM, the indirect fluores-
cent antibody tests were repeated, using all 32 antisera, on 
untreated and CHOase treated neonatal as well as adult kid-
ney sections, from both human and mouse kidneys. It was 
theorized that in neonatal kidney GBM, development may not 
have proceeded to the stage where all carbohydrate groups 
had been added, thus leaving a greater-percentage of cross-
reactive sites unmasked. The results of these comparative 
tests are presented in Tables 12-15. 
Table 12 shows the results of tests with 22 anti-SCM 
antisera, against adult and neonatal NHK. While the number 
of antisera which were positive against adult and neonatal 
GBM were approximately the same (18 and 17, respectively), 7 
of the sera showed stronger fluorescence on adult CHOase 
treated GBM as compared to 4 on neonatal CHOase treated GBM. 
Staining patterns were almost uniformly granular, on both 
adult and neonatal human GBM. Three of the antisera showed 
greater reactivity with neonatal GBM than they did with adult 
GBM, although 3 others showed a decreased reactivity. All 10 
anti-glomerular antisera reacted with adult and neonatal 
human GBM (Table 13) with 2 antisera showing a stronger 
fluorescence on CHOase treated adult sections. Three anti-
sera showed a greater reactivity with neonatal GBM than they 
did with adult. 
TABLE 12 Comparative glomerular staining intensities and patterns of anti-streptococcal cell membrane 
antis~ra vs. adult normal and neonatal normal human kidney sections, before and after CHOase 
treatment. 
vs. Adult NHK-4 vs. Neonatal NHK-1 
CHOase CHOase 
Antiserum Untreated Pattern Treated Pattern Untreated Pattern Treated Pattern 
16. Anti-SCM ±-1+ G 2+ G ± G 1-2+ G 
19A. Anti-SCM ± G 1+ G ± G 1+ G-L 
20A. Anti-SCM 1+ G 1-2+ G ± G ± G 
23. Anti-SCM 2+ G 2-3+ G 2-3+ G 2-3+ G-L 
25. Anti-SCM 1+ G 1-2+ G 1+ G 2+ G 
29. Anti-SCM 1+ G 1-2+ G 1+ G 1-2+ G 
37. Anti-SCM ± G ±-1+ G ± G ± G 
2. Anti-SLS-SCM ± G 1+ G 1+ G 1-2+ G 
4. Anti-SLS-SCM 1+ G 1+ G 0 0 
10. Anti-SLS-SCM 1+ L 2+ G 1+ G 1+ G 
17. Anti-SLS-SCM ± G ± G 1-2+ G 1-2+ G 
9. Anti-SLS-CnBr-SCM ±-1+ G 1+ G 1-2+ G 2+ G 
19B. Anti-SLS-CnBr-SCM 0 0 0 0 
21. Anti-SLS-CnBr-SCM 1+ G 2+ G 1+ G 1+ G 
27. Anti-SLS-CnBr-SCM 1+ G 1+ G 1+ G 2+ G 
22. Anti-SLS-SCM II ±-1+ G 1-2+ G 2+ G 2+ G 
28. Anti-SLS-SCM II 1+ G 2+ G 2+ G 2+ G 
3. Anti-pepsin-CnBr-SCM ±-1+ L 1+ G 1+ G 1+ G 
15. Anti-pepsin-CnBr-SCM 1+ G 1+ G ± G ± G 
18. Anti-CnBr-SCM 0 0 0 0 
24. Anti-pepsin-SCM 0 0 0 0 
30. Anti-pepsin-SCM 0 0 0 0 
NRS 0 0 0 0 
FAb alone 0 0 0 0 
G = granular; L = linear 
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TABLE 13. Comparative glomerular staining intensities and patterns of anti-glomerular 
antisera vs. adult normal and neonatal normal human kidney sections, before 
and after CHOase treatment. 
vs. Adult NHK-4 vs. Neonatal NHK-1 
CHOase CHOase 
Antiserum Untreated Pattern Treated Pattern Untreated Pattern Treated 
Anti-GBM 3+ L 3+ L 3+ L 3+ 
Anti-whole gloms 4+ L 4+ L 4+ L 4+ 
Anti-whole gloms 2+ G-L 2+ G-L 2+ L 2+ 
Anti-PGT-HuGl III 2+ L 3+ L 3+ L 3+ 
Anti-PGT-HuGl III 3+ L 3-4+ L 4+ L 4+ 
Anti-SLS-CnBr-GBM 3+ L 3-4+ L 3+ L 3+ 
Anti-SLS-CnBr-GBM 2+ L 3+ L 3+ L 3+ 
Anti-SLS-CnBr-GBM 3+ L 3+ L 3+ L 3+ 
Anti-GBM-trypsin 1-2+ G 2+ G 2+ L 2+ 
resistant 
20B. Anti-PGT-HuGl II 3+ L 3+ L 3+ L 3+ 
NRS 0 0 0 0 
FAb alone 0 0 0 0 
G = granular; L = linear 
Pattern 
L 
L 
L 
L 
L 
L 
L 
L 
L 
L 
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TABLE 14. Comparative glomerular staining intensities and patterns of anti-streptococcal 
cell membrane antisera vs. adult normal and neonatal normal mouse kidney sec-
tions, before and after CHOase treatment. 
vs. Adult NMK-2 vs. Neonatal NMK-1 
CHOase CHOase 
Antiserum Untreated Pattern Treated Pattern Untreated Pattern Treated 
16. Anti-SCM 0 ± G 0 0 
19A. Anti-SCM 0 ± G 1+ G 1+ 
20A. Anti-SCM 0 0 1-2+ G 1-2+ 
23. Anti-SCM 0 0 2+ G 2+ 
25. Anti-SCM 0 0 1+ G 1-2+ 
29. Anti-SCM 0 0 2+ G 2+ 
37. Anti-SCM 0 0 1+ G 1+ 
2. Anti-SLS-SCM ± G ± G 1+ L 1+ 
4. Anti-SLS-SCM 1+ G 1+ G 1+ L 1+ 
10. Anti-SLS-SCM 0 0 1+ G 1+ 
17. Anti-SLS-SCM 0 0 0 0 
9. Anti-SLS-CnBr-SCM ±-1+ L 1+ G 1-2+ G 1-2+ 
19B. Anti-SLS-CnBr-SCM 0 ±-1+ G 1+ G 1+ 
21. Anti-SLS-CnBr-SCM 0 0 1+ G 1+ 
27. Anti-SLS-CnBr-SCM 0 0 1-2+ G 1-2+ 
22. Anti-SLS-SCM II 0 0 1+ G 1+ 
28. Anti-SLS-SCM II 0 0 1+ L 1+ 
3. Anti-oeosin-CnBr-SCM ± G ± G ± G ± 
15. Anti-Peosin-CnBr-SCM 0 ± G ± G 1+ 
18. Anti-CnBr-SCM 0 ± G ± G 1+ 
24. Anti-oeosin-SCM 0 0 1+ G 1+ 
30. Anti-oeosin-SCM 0 0 0 0 
NRS 0 0 0 0 
FAb alone 0 0 0 0 
G = granular; L = linear 
Pattern 
G 
G 
G-L 
G-L 
G 
G 
L 
G 
G 
G 
G 
G 
G 
G 
G 
G 
G 
G 
G 
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TABLE 15. Comparative glomerula!' staining intensities and patte~s of anti-glomerulaI> 
antisera vs. adult normal and neonatal normal mouse kidney sections, before 
and after CHOase treatment. 
vs. Adult NMK-2 vs. Neonatal NMK-1 
CHOase CHOase 
Antiserum Untreated Patte~ Treated Pattern Untreated Pattern Treated 
1. Anti-GBM 1+ L 1+ L 1+ L 1+ 
B. Anti-whole gloms 1-2+ L 2+ L 2-3+ L 2-3+ 
11. Anti-whole gloms 1-2+ L 2+ L 2-3+ L 2-3+ 
5. Anti-PGT-HuGl III 1+ G 1-2+ G 2+ L 2+ 
7. Anti-PGT-HuGl III 2+ G 2+ G 1-2+ L 1-2+ 
6. Anti-SLS-CnBr-GBM 2+ G 2+ G 2+ G 2+ 
12. Anti-SLS-CnBr-GBM 1+ G 2+ G 2+ L 2-3+ 
13. Anti-SLS-CnBr-GBM 1+ G 2+ G 2+ L 2+ 
14. Anti-GBM-trypsin ± L 1+ G 1+ G 2+ 
resistant 
20B. Anti-PGT-HuGl II 1+ L 2+ G 2+ L 3+ 
NRS 0 0 0 0 
FAb alone 0 0 0 0 
G = granular; L = linear 
Patte~ 
L 
L 
G 
G 
G 
G 
L 
G 
G 
G 
-...:I 
°' 
~~ 
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Table 14 shows similar comparative tests of the anti-
SCM antisera on neonatal and adult NMK. Nine of the 22 sera 
were positive on adult NMK, while 19 were positive on neo-
natal NMK. Of the 9 which were positive on adult NMK, 5 
were positive apparently due_to CHOase pretreatment of the 
sections. Only 2 of the 19 positive sera showed an in-
creased fluorescence intensity on CHOase pretreated neonatal 
NMK as compared to untreated sections. All 10 glomerular 
antisera reacted with adult and neonatal NMK. Four showed 
increased fluorescence after CHOase treatment on adult, and 
only 2 showed similar increased fluorescence on CHOase 
treated neonatal NMK. Seven of the antisera showed a great-
er reactivity with neonatal GBM than they did with adult. 
In all of the comparative tests, staining patterns 
were similar to that which was found earlier. Anti-SCM anti-
sera gave mostly granular staining patterns on both adult 
and neonatal mouse and human kidney sections, while anti-
glomerular antisera gave linear patterns on human kidney and 
variable patterns on mouse GBM. 
8. Comparative FAb titrations of anti-SCM and anti-glomeru-
lar antisera on adult and neonatal, human and mouse kidney 
sections. To quantitate the differences in the reactivities 
of the anti-SCM and anti-glomerular antisera with adult and 
neonatal GBM, antiserum titrations were carried out. Anti-
sera were chosen.which showed stronger intensities against 
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neonatal sections, no change in intensity, and in one case, 
a weaker intensity, as compared to adult sections, to see if 
their antibody titers correlated with their observed inten-
sity differences. The results are presented in Tables 16 
and 17, along with the undiluted intensities observed in 
these tests. 
As can be seen, those antisera which showed greater re-
activity with neonatal kidney sections, as measured by inten-
sity, also showed higher titers agains~ neonatal GBM as com-
pared to adult. In most cases, the titers found against neo-
natal GBM were the same as those found against CHOase treated 
adult GBM, which were higher than those found against un-
treated adult GBM. 
Those antisera which showed no differences in staining 
intensities on adult and neonatal GBM, also showed no titer 
differences. 
Carbohydrase pretreatment of neonatal mouse or human 
kidney sections had little or no effect on the subsequent 
antisera titers found, unlike the results found with some 
antisera on adult CHOase treated sections. 
9, In vivo fluorescent antibody tests with anti-SCM and 
anti-glomerular antisera in adult and neonatal mice. The 
differential reactivity of adult and neonatal kidney GBM, as 
reflected by in vitro fluorescent antibody tests, was fur-
ther tested in an in vivo system. Adult and neonatal mice 
TABLE 16. Indirect fluorescent antibody titrations of anti-glomerular 
and anti-streptococcal cell membrane antisera vs. adult and 
neonatal normal human kidney sections. 
vs. Adult NHK-4 vs. Neonatal NHK-1 
Antiserum CHOase CHOase 
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Against Untreated treated UntI>eated Treated 
9. SLS-CnBr-SCM 1/3 1/6 1/6 1/6 
(±-1+)a (1-2+) (1-2+) (2+) 
22. SLS-SCM, DEAE 1/6 1/9 1/9 1/9 
fraction II (±-1+) (1-2+) (2+) (2+) 
3. Pepsin-CnBr-SCM 1/7 1/7 1/7 1/7 
(1+) (1+) (1+) (1+) 
20A. SCM 1/6 1/8 1/2 1/'+ 
(1+) (1-2+) (+) (±-1+) 
5. PGT-HuGl III 1/128 1/192 1/192 1/192 
(2+) (3+) (3+) ( 3+) 
11. Whole glomeruli 1/192 1/192 1/192 1/192 
(2+) (2+) (2+) (2+) 
a Values in parentheses represent undiluted staining intensities. 
Anti-SCM antisera were titrated linearly in successive one-fold dilutions; 
anti-glomerular antisera were titrated linearly in successive 16-fold 
dilutions. 
TABLE 17. Indirect fluorescent antibody titrations of anti-glomerular' 
and anti-streptococcal cell membrane antisera vs. adult and 
neonatal mouse kidney sections. 
vs. Adult NMK-2 vs. Neonatal NMK-1 
Antiserum CHOase CHOase 
Against Untreated treated Untreated treated 
9. SLS-CnBr-SCM 1/4 1/6 1/7 1/7 
(±-1+)a (1+) (2+) (2+) 
19B. SLS-CnBr-SCM 0 1/2 1/4 1/4 
(O) (±) (1+) (1+) 
4. SLS-SCM 1/4 1/4 1/4 1/3 
(1+) (1+) (1+) (1+) 
12. SLS-CnBr 1/16 1/32 1/32 1/32 
soluble GBM (1+) (2+) (2+) (2-3+) 
14. Trypsin-resistant 1/4 1/16 1/16 1/32 
GBM (±) (1+) (1+) (2+) 
6. SLS-CnBr 1/16 1/16 1/16 1/8 
soluble GBM (2+) (2+) (2+) (2+) 
a Values in parentheses represent undiluted staining intensities. 
Anti-SCM antisera were titrated linearly in successive one-fold dilutions; 
anti-glomerular antisera were titrated linearly in successive four-fold 
dilutions. 
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were inoculated intraperitoneally with 1.0 or 0.2 ml, re-
spectively, of an antiserum, and four h later their kidneys, 
livers and lungs were removed and sectioned. Fluorescein-
conjugated goat anti-rabbit gamma globulin antiserum was ap-
plied to the sections, and they were observed for staining. 
The results are presented in Table 18, and in Fig. 4 and 5, 
As can be seen, little reactivity was found with the adult 
kidney sections, while considerable antibody binding occured 
with neonatal GBM, which parallels the in vitro studies. Anti-
glomerular antisera gave linear patterns of fluorescence, 
while anti-SCM antisera, with one exception, gave granular 
staining patterns. With the control sections, lung tissues 
did give some staining activity with the antisera, especially 
in the neonatal mice, but liver tissues were negative. 
B. Quantitative Chemical Analyses of Adult and Neonatal, 
Human and Mouse GBM. 
Since it seemed that neonatal GBM acted as if there 
was much less carbohydrate masking of antigenic sites, as 
compared to adult GBM, quantitativ~ chemical analyses, for 
carbohydrates and amino acids, were performed on isolated 
GBM from human and mouse kidneys. 
1. Quantitative carbohydrate analyses of adult and neonatal, 
human and mouse GBM. The results of analyses are presented 
in Table 19. Total hexoses, fucose and hexosamine contents 
were found to increase with age. Sialic acid content was 
8. 
TABLE 18. In vivo indirect fluorescent antibody tests (intensities and patterns) of 
anti-glomerular and anti-streptococcal cell membrane antisera vs. adult 
and neonatal mice. 
Adult Mice Neonatal Mice 
Kidney Kidney 
Antiserum glomeruli Pattern Liver Lung glomeruli Pattern Liver 
Anti-whole gloms ± L 0 ± 2+ L 0 
Lung 
1+ 
20B. Anti-PGT-HuGl II 1+ L 0 ± 2-3+ L 0 1+ 
4. 
23. 
28. 
Anti-SLS-SCM 0 ± ± 1-2+ G ± ±-1+ 
Anti-SCM ±-1+ G 0 0 1-2+ L 0 ± 
Anti-SCM II ± G 0 0 1+ G 0 1+ 
NRS 0 0 0 0 0 ± 
G = granular; L = linear 
Adult mice were injected intraperitoneally with 1.0 ml of antiserum, and neonatal mice 
with 0.2 ml. Four hours after injection the mice were sacrificed and their kidneys, 
livers and lungs removed, sectioned and stained with fluorescent antibody. See Materials 
and Methods. 
()'.) 
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Fig. 4. In vivo fluorescent antibody tests in neo-
natal mice. Animals were injected intraperitoneally with 
0.2 ml antiserum. Four hours later the kidneys were rem-
oved, sectioned and treated with fluorescein-conjugated 
sheep anti-rabbit gamma globulin. Top: anti-SLS--SCM #4, 
showing 1-2+ granular fluorescence; Bottom left: anti-
SCM #23, showing 1-2+ linear fluorescence; Bottom right: 
anti-SLS-SCM II #28, showing 1+ granular fluorescence. 
Fig. 5. In vivo fluorescent anti-
body tests in neonatal mice. Animals 
were injected intraperitoneally with 
0.2 ml antiserum. Four hours later the 
kidneys were removed, sectioned and 
treated with fluorescein-conjugated 
sheep anti-rabbit g;3.mma globulin. Top: 
anti-whole gloms #8, showing 2+ linear 
fluorescence; Bottom: anti-PGT-HuGl II 
#20, showing 2-J+ linear fluorescence. 
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TABLE 19. Quantitative carbohydrate determinations of adult 
and neonatal, human and mouse GBM. 
Human Mouse 
Percent Percent 
Carbohydrate Neonatal Adult Neonatal Adult 
Total hexosea 4.32d 6.09 4.18 4.77 
Sialic acid 1.91 0.93 0.78 1.19 
Fucose 0.19 0.42 0.38 0.68 
Hexosaminesb 0.55 0.96 0.54 0.68 
Total 6.97 Carbohydratec 8.40 5.88 7.32 
a Determined using a galactose:glucose:mannose, 2:1:1 standard 
b Determined on amino acid analyzer 
c Sum of individual determinations 
d Results represent the average of at least two separate 
determinations 
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found to decrease with age in human GBM and increase in mouse 
GBM. In both human and mouse GBM, total carbohydrate in-
creased approximately 1.4% from neonatal to adult. Such an 
increase would be expected if the masking effect was real. 
2. Amino acid analysis of adult and neonatal, human and 
mouse GBM. Comparative amino acid compositions of adult and 
neonatal GBM's are presented in Table 20. Two important com-
parisons may be made, that of lysine and hydroxylysine (which 
links to carbohydrate units), and proline and hydroxyproline. 
In the human GBM lysine decreases with age, approximately 
1.7%, with a corresponding increase in hydroxylysine of ap-
proximately 1.5%, indicating an increased capacity of adult 
GBM for carbohydrate binding. Similarly in mouse GBM lysine 
decreases approximately 0.42% with a corresponding increase 
in hydroxylysine of approximately 0.25%. Hydroxyproline con-
tent, which is an indicator of aging and content of collage-
nous material, increases with age in both human and mouse 
GBM's, while proline content increases in the human GBM and 
decreases in the mouse GBM. Most other amino acids remained 
fairly stable from neonatal to adult GBM, with the exception 
of glycine in the human GBM, which increased by over 3% from 
neonatal to adult. 
C. Physical and Immunological Characterization of the GBM 
and SCM Antigens. 
TABLE 20. Amino acid analyses of adult and neonatal, human 
and mou5e GBM. 
Human Mouse 
Percent Percent 
Amino Acid Neonatal Adult Neonatal Adult 
Lysine 6.5 3.8 5.2 4.8 
Histidine 1.4 0.4 2.5 1.2 
Ammonia 1.1 0.8 0.9 0.8 
Arginine 7.7 5.9 6.4 6.2 
Hydroxylysine 0.7 2.2 0.7 0.9 
Aspartic acid 7.1 6.7 7.9 7.4 
Threonine 3.8 3.1 3.8 4.8 
Serine 5.1 3.7 4.3 4.9 
Glutamic acid 11.8 11.5 11.6 11.6 
Pro line 4.7 6.1 5.2 4.6 
1/2 Cystine 1.2 0.9 1.6 1.4 
Glycine 7.2 10.3 7.4 7.0 
Alanine 5.0 5.2 4.8 4.7 
Valine 4.0 3.1 4.3 4.2 
Methionine 1.4 1.5 1.8 1.8 
Isoleucine 3.3 2.9 3.6 3.5 
Leucine 7.2 6.1 7.3 7.5 
Tyrosine 2.8 2.2 3.0 3.2 
Phenylalanine 3.3 3.3 4.0 4;0 
Hydroxyproline 2.6 9.4 2.8 4.3 
TOTAL 88.9 89.9 89.8 89.8 
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1. Solubilization of adult human GBM and group A, type 12 
SCM. In order to evaluate further the cross-reactivity be-
tween human glomerular basement membrane and type 12 strepto-
coccal cell membrane, samples were solubilized using enzyma-
tic or chemical procedures. GBM was solubilized by either 
trypsin or collagenase digestion, and SCM was solubilized by 
treatment with either sodium lauryl sulfate (SLS), trypsin, 
or a combination of SLS and trypsin. 
Trypsin and collagenase enzymatic digestion of human 
GBM resulted in recoveries of 57% and 16.6% soluble material, 
respectively. With trypsin, 12% of the material was re-
coverable as insoluble, trypsin-resistant GBM, and 31% was 
lost, apparently in dialysis. After collagenase digestion, 
21.4% of the starting material was insoluble, collagenase-
resistant GBM, and 61.9% was lost. 
Solubilization of SCM with SLS resulted in a 52.8% re-
covery of soluble membrane, with 13.5% insoluble, and 33,7% 
lost. Trypsinization of SCM yielded 18% recoverable solu-
bilized membrane, with 7.6% insoluble and 74.4% lost. Tryp-
sinization of SLS solubilized SCM yielded a 57% recovery of 
solubilized starting material, with 3.5% becoming insoluble, 
and the rest lost. 
2. Polyacrylamide gel electrophoresis of solubilized GBM and 
SCM. The solubilized membrane-s from group A, type 12 strep-
tococci or human,kidney glomeruli were electrophoresed in 
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7.5% polyacrylamide gels. The number of bands, stained with 
either 1% Buffalo Black or 0.5% Coomassie Blue were as fol-
lows: GEM-trypsin, 11 bands; GBM-collagenase, 11 bands; SLS-
SCM, 10 bands; SCM-trypsin, 10 bands; SLS-SCM-trypsin, 11 
bands. Each preparation had its own distinctive banding pat-
tern, and although some bands in different preparations oc-
cupied similar regions in the gels, no conclusions as to 
banding similarities could be drawn by comparing individual 
gels. 
3, Fractionation of SLS-SCM, SLS-SCM-trypsin and GEM-trypsin 
by DEAE-cellulose column chromatography. Samples for frac-
tionation were dissolved in 2.0 ml of 0.005 M phosphate buf-
fer, pH 7.8, and applied to columns of DEAE-cellulose, pre-
viously equilibrated with the same buffer. Fractions were 
eluted in a step-wise manner with phosphate buffers of in-
creasing molarities and decreasing pH's. The results of such 
elutions are presented in Fig. 6-8. 
SLS-SCM gave 6 peaks (Fig.6) which were collected, di-
alized and lyophilized. The combined dry weights of the 6 
peaks represented 37,5% of the original sample placed on the 
column, with peak I being 81.3% of the total recovery. 
Fractionation of SLS-SCM-trypsin resulted in 10 major 
peaks (Fig. 7), two of which (peaks VI and VII) were sepa-
rated into two fractions each on the basis of pH measurements 
of the eluates. The combined dry weights of the dialyzed, 
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Fig. 6. DEAE-cellulose elution pattern of SLS-SCM. 
Peaks, labled with Roman numerals, were measured at 280 nm. 
100 mg of SLS-SCM was placed on a 1x15 cm column (10 ml bed 
volume) of DEAE-cellulose. Elution was carried out with 
sodium phosphate buffers of increasing molarities and 
decreasing pH's. See Materials and Methods. 
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Fig. 7, DEAE-cellulose elution pattern of SLS-SCM-
trypsin. Peaks, labled with Roman numerals, were measured 
at 280 nm. 75 mg of SLS-SCM-trypsin was placed on a 1x15 cm 
(10 ml bed volume) column of DEAE-cellulose. Elution was 
carried out with sodium phosphate buffers of increasing 
molarities and decreasing pH's. See Materials and Methods. 
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Fig. 8. DEAE-cellulose elution pattern of GEM-trypsin. 
Peaks, labled · with Roman numerals, were measured at 280 nm. 
50 mg of GEM-trypsin was placed on a 1x15 cm (10 ml bed 
volume) column of DEAE-cellulose. Elution was carried out 
with sodium phosphate buffers of increasing molarities and 
decreasing pH's. See Materials and Methods. 
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lyophilized fractions represented 35.4% of the original sam-
ple, with no one peak containing a major amount. 
Fractionation of GEM-trypsin resulted in 7 major peaks 
(Fig. 8) which were resolved into 12 fractions on the basis 
of pH measurements of the eluates. Their combined weights 
represented 34.8% of the original sample, with peak I (frac-
tions a, b, c and d) containing 46.0% of the total recovery. 
4. Immunodiffusion tests with solubilized SCM and GBM, DEAE 
fractions, and anti-SCM and anti-glome:r·ular antisera. The 
solubilized SCM and GBM preparations, and all DEAE fractions 
were initially screened in irnrnunodiffusion tests using four 
antisera - two anti-glomerular antisera and two cross-reac-
ti ve anti-SCM antisera, shown to be potent by the fluores-
cent antibody test. The DEAE fractions of SLS-SCM and SLS-
SCM-trypsin were found to be non-reactive, even against homo-
. logous antisera. However, the solubilized, unfractionated 
preparations were reactive, with all four sera tested. The 
solubilized GBM preparations and the GBM-trypsin DEAE frac-
tions gave opposite results. Unfractionated, soluble GBM 
was poorly reactive even with homologous antisera. However 
several DEAE fractions, especially peaks Iab and IIIa, were 
highly reactive, giving precipitin lines with both glomerular 
and SCM antisera. The reactive GBM and SCM soluble prepara-
tions were then tested in expanded Ouchterlony tests with 
several glomerular and SCM antisera. The results are pre-
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sented in Table 21, as well as Fig. 9 and·10. 
Not all antisera tested were reactive, even with some 
homologous antigen preparations. The most reactive soluble 
membrane preparations were SLS and trypsin solubilized SCM 
and DEAE fractions Iab and IIIa of trypsin solubilized GBM. 
Several cross-reactions, between antisera and solubilized 
membrane preparations were noted, but in no cases were lines 
of identity seen between SCM and GBM antigens. However when 
several SCM and glomerular antisera were tested against a 
single antigen, lines of identity were seen, indicating the 
antisera were reacting with the same antigenic component. 
D. Summation of Cross-Reactivity Between Group A, Type 12 
Streptococcal Cell Membrane and Human and Mouse Glomer-
ular Basement Membrane. 
A summary of the cross-reactive activity of the SCM 
and glomerular antisera is presented in Tables 22 and 23. 
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TABLE 21. IllD!lunodiffusion tests with solubilized SCM and GEM preparations. 
Number of IllD!lunodiffusion Lines Against 
SLS- SLS-SCM SCM- SLS-SCM GEM- GEM- GEM-trypsin GEM-trypsin 
Antis era SCM fraction I trypsin trypsin collagenase trypsin fraction Iab fraction IIIa 
Glomerular 
1. Anti-GEM 1 1 0 0 1 1 NT 2 
5. Anti-PGT-HuGl III 0 0 1 0 1 0 2 2 
7. Anti-PGT-HuGl III 0 0 1 0 0 0 2 1 
8. Anti-whole sloms 1 0 0 0 1 0 NT 1 
11. Anti-whole sloms 0 0 1 0 1 1 2 2 
14. Anti-GEM-trypsin 0 0 1 0 1 1 1 1 
resistant 
20E. Anti-PGT-HuGl II 0 0 1 0 1 1 1 1 
SCM 
2. Anti-SLS-SCM 1 1 0 0 0 0 1 0 
4. Anti-SLS-SCM 1 1 0 0 0 0 1 0 
9. Anti-SLS-CnEr-SCM 0 0 0 0 0 0 1 0 
10. Anti-SLS-SCM 1 0 0 0 0 1 1 0 
16. Anti-SCM 1 0 0 0 1 0 1 1 
18. Anti-CnBr-SCM 1 0 1 0 0 0 1 1 
20A. Anti-SCM 0 0 0 0 0 0 1 0 
21. Anti-SLS-CnBr-SCM 1 0 1 1 0 0 0 0 
22. Anti-SLS-SCM II 3 0 2 1 0 0 1 1 
28. Anti-SLS-SCM II 1 0 1 1 0 0 1 1 
23. Anti-SCM 0 0 0 0 0 0 1 0 
NRS 0 0 0 0 0 0 0 0 
NT = not tested 
'° \.)\ 
·Fig• 9 .• Immunodiffusion with anti-SCM · and 
anti-glomerular antisera. Top: center wel,l, GBM 
frac·tion ·rab; well 1, anti-SCM #20A; we,;i.1 2 '· 
~' ant.i-SLS-SCM #2; well J, anti-SCM #23; well 4, 
w,.,r\ . .antI-,:sLS-SCM #4; well 5, anti-SLS-CnBr-SCM #9; 
··':iV· well 6, anti- SLS-SCM #10. Bottom: center well, 
.GBM fraction Ia.b; well 1, anti-SCM //16 ;. well 2, 
~nti-SLS-SCM #17; well 3, anti-CnBr-SCM #18; 
well 4, anti-SCM #19; well 5, anti-PGT-HuGl III 
#5; well 6, anti-PGT-HuGl II #20B. 
9\'"J!'., · Cl 
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Fig. 10. Immunodiffusion with anti-SCM and 
anti-glomerular antisera. Top: center well, GBM 
fraction IIIa; well 1, anti-SLS-SCM II #28; well 
2, anti-PGT-HuGl III #5; well 3, anti-CnBr-SCM 
#18; well 4, anti-SLS-CnBr-SCM #21; well 5, anti-
SCM #20A. Bottom: center well, anti-SLS-SCM II 
#28; well 1, SLS-SCM; well 2, GBM fraction Iab; 
well 3, SCM-trypsin; well 4, SLS-SCM fraction I; 
well 5, GBM fraction Iab; well 6, SCM-trypsin. 
TABLE 22. 
Antigen 
1. Whole SCM 
2. SLS soluble SCM 
3. DEAE fraction II 
SLS soluble SCM 
4. CnBr soluble SCM 
5. SLS-CnBr soluble SCM 
6. Pepsin-CnBr-SCM 
-
7. Pepsin soluble SCM 
TOTAL 
I11DDunologic reactivities of rabbit anti-streptococcal cell membrane 
antisera. 
Number Positive/Number Tested 
Number Fluorescent Antibody Tests I11DDunodiffusion Tests 
of Adult and Neonatal SLS or trypsin Collagenase or 
Antisera Mouse GBM Human GBM Soluble SCM trypsin soluble GBM 
7 6/7 7/7 1/3 3/3 
4 3/4 4/4 2/2 1/2 
2 2/2 2/2 2/2 2/2 
1 1/1 0/1 1/1 1/1 
4 4/4 4/4 1/2 1/2 
2 2/2 2/2 0/1 0/1 
2 1/2 2/2 0/1 0/2 
22 19/22 21/22 7/12 8/13 
'° Q) 
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TABLE 23. 
Antigen 
1. Whole glomeruli 
-
2. Trypsin soluble 
glomeruli-DEAE 
fraction II 
--
3. Trypsin soluble 
glomeruli-DEAE 
fraction III 
4. GBM 
5. SLS-CnBr-GBM 
6. Trypsin resistant GBM 
TOTAL 
Immunologic reactivities of rabbit anti-glomerular and glomerular 
basement membrane antisera. 
Number Positive/Number Tested 
Number Fluorescent Antibody Tests Inununodiffusion Tests 
of Adult and Neonatal SLS or trypsin Collagenase or 
Antis era Mouse GBM Human GBM Soluble SCM trypsin soluble GBM 
2 2/2 2/2 2/2 2/2 
1 1/1 1/1 1/1 1/1 
2 2/2 2/2. 2/2 2/2 
1 1/1 1/1 1/1 1/1 
3 3/3 3/3 0/3 0/0 
1 1/1 1/1 1/1 0/1 
10 10/10 10/10 7/10 6/7 
'° 
'° 
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CHAPTER IV 
DISCUSSION 
A. Fluorescent Antibody Tests 
Reciprocal immunologic .. cross-reactivity, between the 
cell membrane of group A, type 12 Streptococcus pyogenes, a 
nephritogenic organism, and human glomerular basement mem-
brane, has been postulated to be a major factor in the mech-
anism of development of post-streptoco~cal glomerulonephri-
tis (67), Evidence presented here reconfirms that cross-
reactive antigens do exist on both membrane-types. In in-
direct fluorescent antibody tests, several anti-strepto-
coccal cell membrane antisera were found to react immuno-
logically with human glomerular basement membrane (Tables J, 
5, 6 and 12). In addition, antiserum absorption tests with 
various streptococcal cell membrane preparations and human 
glomerular basement membrane established the reciprocal na-
ture of the cr~ss-reaction (Tables 7-10). Anti-SCM antisera 
also cross-reacted with mouse GBM, which may be of value in 
eventually establishing an animal model for the disease. 
Positive in vivo tests performed here (Table 18, Fig. 4 and 
5) have substantiated the feasibility of such an experimental 
approach, which has been attempted in other animal species, 
notably dogs (95,96), Rhesus monkeys (64,65) and rats (63). 
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It has been well demonstrated that GBM antigens, and 
principally those with nephrotoxic capacities, are glycopro-
teins (35,68,80). Similarly major antigens in streptococcal 
cell membrane are glycoproteins (50,52). A major aspect of 
this research has been an evaluation of the role of carbohy-
drate in the cross-reaction between GBM and SCM glycoprotein 
antigens. It has thus been demonstrated that carbohydrate 
units exert a masking effect on the cross-reactive antigens. 
In fluorescent antibody tests several antisera, both homo-
logous and cross-reacting, gave increasing GBM fluorescent 
intensities, indicating greater antibody binding, on adult 
kidney sections which had been pretreated with carbohydrases, 
as compared to duplicate untreated sections (Tables 1-6). 
Initial fluorescent antibody titrations also demonstrated 
that both homologous and heterologous antisera had higher 
titers on CHOase treated adult human kidney sections as com-
pared to untreated sections (Table 5), In addition, the 
antiserum absorption studies revealed that both GBM and some 
SCM preparations had greater abso~ptive capacities following 
their treatment with CHOase (Tables 7-10). It thus appears 
that the cross-reactive antigens are protein in nature, with 
no contribution of carbohydrate to the antigenic determin-
ants which cross-react. Rather, carbohydrate units appar-
ently serve to protect or mask such determinants from anti-
body attachment. 
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Neonatal GBM, from both mice and humans, was found to 
be somewhat more reactive with glomerular and SCM antisera 
than adult GBM (Tables 12-15). Both fluorescent intensities 
and titers were increased, with several antisera, on neo-
natal GBM as compared to adult (Tables 16 and 17). In addi-
tion, CHOase had little or no effect on the fluorescent in-
tensities or titers found on neonatal GBM. It thus appeared 
that the GBM antigenic determinants in neonates were un-
masked, or had less carbohydrate masking than the determin-
ants in adult GBM. In the comparative fluorescent antibody 
titrations, the undiluted staining intensities and titers 
found on neonatal kidney sections were similar to the inten-
sities and titers found on CHOase treated adult sections. 
In human cases of post-streptococcal glomerulonephri-
tis, granular GBM fluorescent staining patterns have been 
cited as evidence for immune-complex deposition (5,78) and 
of an immune-complex mechanism for the pathogenesis of the 
disease (78). In the studies presented here, it was found 
that anti-SCM antisera which cross-react with human (or 
mouse) GBM causes similar granular GBM fluorescent staining 
patterns (Tables 1, 3, 12 and 14; Fig. 2 and 3). Thus pre-
vious conclusions as to the nature of observed granular fluo-
rescence in clinical cases of post-streptococcal glomerulo-
nephri tis may have been misinterpretations (109,110,111). 
Treser et al. (109, 110,111) found that fluorescein-conju-
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gated IgG from patients with post-streptococcal glomerulo-
nephritis stained the GBM, in a granular pattern, of sections 
taken from such patients. They concluded that the granular 
nature of staining observed was due to SCM antigens deposited 
along the GEM, which subsequently reacted with anti-SCM an-
tibodies, although the presence of such SCM antigens was 
never demonstrated. Their results could also be interpreted 
to be the result of anti-SCM antibodies cross-reacting with 
GEM, resulting in a granular staining pattern, as was found 
here (Fig. 2). 
Linear fluorescent staining patterns found with anti-
glomerular or GEM antisera can be explained by the fact that 
the immunogens used to produce the antisera contain the fUll 
complement of antigenic determinants found on GEM, which 
would lead to the antiserum containing the full complement 
of antibodies. Thus most antigenic sites would be filled in 
subsequent tests, leading to a linear fluorescent pattern. 
Anti-SCM antisera, on the other hand, contains antibodies 
which cross-react with probably on~y one antigenic determin-
ant on the GBM, of which many are probably located under car-
bohydrate side chains, and therefore dispersed along the GBM, 
leading to a granular staining pattern. 
It may be that not all cross-reacting determinants are 
located beneath carbohydrate side chains, which would ex-
plain the effect of CHOase treatment on adult sections. Un-
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treated GBM may have a certain percentage.of cross-reacting 
determinants unmasked, allowing some antibody attachment. 
Subsequent treatment with CHOase would further unmask more 
determinants, leading to greater antibody binding and subse-
quent increased fluorescence.and fluorescent antibody titers. 
Such a conclusion is in part supported by the findings of 
Spiro (103,104). He found that approximately 70% of the hy-
droxylysine residues in beef GBM are disaccharide-bound, 
leaving 30% unbound, or "unmasked." A:--similar situation may 
exist with asparagine, which probably is the linkage site to 
the GBM heteropolysaccharide (50,104), although neither point 
has been fully proven yet, nor is it knovm whether or not the 
antigenic determinant which cross-reacts with SCM antisera 
lies under the disaccharide on collagenous GBM or the hetero-
polysaccharide on the glycoprotein portion. Lange's (50) 
finding that all cross-reacting GBM peptides, isolated by 
papain digestion, high voltage electrophoresis and chromato-
graphy, contained hydroxyproline, hydroxylysine and high con-
tents of asparagine, as well as sialic acid, hexosamines and 
hexoses, suggests that the cross-reacting determinant lies 
under the heteropolysaccharide attached to asparagine. Neo-
natal GBM, which showed little or no effect of CHOase treat-
ment, must then have much less carbohydrate masking, and, as 
a consequence, less total carbohydrate. 
r 
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B. Quantitative Chemical Analyses of Adult and Neonatal, 
Human and Mouse GBM 
Carbohydrate analyses supported the hypothesis that 
the differential reactivity of neonatal and adult GBM was due 
to a difference in carbohydrate content. Total carbohydrate 
in both mouse and human neonatal GBM was approximately 1.4% 
less than that found in adults ~able 19). In neonatal mouse 
GBM, all individual carbohydrates - hexoses, sialic acid, 
fucose and hexosamines - were less in content than in adult 
mouse GBM. In the human GBM system, sialic acid content was 
surprisingly higher in neonatal GBM than in adult, with the 
other individual carbohydrates lower in content. No ration-
al explanation for this discrepancy can be suggested. Amino 
acid analyses performed on adult and neonatal GBM's support 
the carbohydrate findings (Table 20). Particularly with hy-
droxylysine, which is known to be a linkage point to carbo-
hydrate (104), the content was significantly less in both 
human and mouse neonatal GBM. The rise in hydroxylysine with 
age corresponded to a decrease in lysine content in adults, 
which indicates that as the kidney matures, hydroxylation of 
lysine residues occurs, allowing increased carbohydrate bind-
ing, which was in fact found. Thus as the kidney matures, 
carbohydrate units must increase to a plateau. Knowledge of 
the relationship between renal carbohydrate content and age 
could easily be obtained by analysis of GBM from mice of dif-
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ferent.ages. 
C. Physical and Immunological Characterization of GBM and 
SCM Antigens 
The cross-reactivity between human GBM and group A, 
type 12 SCM was further supported by immunodiffusion analy-
ses, using the same antisera employed in the fluorescent an-
tibody tests, and solubilized SCM and GBM, as well as DEAE-
cellulose column chromatography fractions isolated from them 
(Table 21; Fig. 9 and 10). It would appear that trypsiniza-
tion was the better of the solubilization techniques employed 
in the attempts to yield cross-reacting antigenic prepara-
tions. The DEAE isolated fractions of human GBM, notably 
fractions Iab and IIIa, contained antigens which showed cross-
reactivi ty with SCM antisera, while the parent preparation 
reacted poorly or not at all. This might be expected since 
the unfractionated soluble GBM would contain less of the 
cross-reacting antigen, in proportion, than in the fractions 
separated and collected by chromatography, where they would 
be more concentrated. However, with the SCM solubilized pre-
parations, the opposite was surprisingly found. Virtually 
none of the DEAE isolated SCM fractions cross-reacted with 
glomerular antisera while the parent preparations, particu-
larly SLS-SCM and SCM-trypsin, did. 
When single antisera we~e tested against several anti-
gens, of both GBM and SCM origin, precipitin lines appeared 
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against both, but did not form lines of identity. However, 
when a single cross-reacting antigen was tested in the same 
system against several antisera, of both GBM and SCM speci-
ficities, lines of identity appeared between the antisera, 
indicating they were all rea('.ting with the same component. 
D. Cross-Reactivity Between Human GBM and Group A, Type 
12 SCM as a Cause of Post-Streptococcal Glomerulo-
nephri tis 
There can be little doubt that antigens present in hu-
man GBM and group A, type 12 streptococcal cell membrane 
cross-react. As of yet attempts to evaluate the cross-re-
activi ty of streptococcal cell membranes from other nephri-
togenic streptococci with human GBM have not been performed. 
Nevertheless it seems apparent that non-nephritogenic strep-
tococci do not possess antigens that might lead to the dis-
ease, as has been found here in the absorption studies 
(Tables 7-10), as well as by others (7,67,110), despite the 
fact that the cell membranes of nephritogenic and non-neph-
ritogenic streptococci cross-react (25,26). 
For years researchers have been attempting to pinpoint 
the specific factor(s) of nephritogenic streptococci that 
differentiate them from non-nephritogenic strains, and the 
factors that would influence the progression of streptococ-
cal infection to glomeruloneph~itis. Noble and Vosti (83), 
using several parameters other than antigenicity, tested a 
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nephritogenic and a non-nephritogenic strain of group A 
streptococci and found no differences in colonial morphology, 
hemolysis, antibiotic resistance, starch accumulation and 
DNase production. Hardin et al. (JO) found no difference 
between nephritogenic and non-nephritogenic group A strepto-
cocci as to their production of streptolysins O and S, strep-
tokinase, hyaluronic acid, hyaluronidase, proteinase and 
erythrogenic toxin. Wilson (121) found no difference be-
tween sequelae producing organisms and non-sequelae producing 
group A streptococci with respect to their leukotoxicity. 
Kuttner (48), however, found that nephritogenic group A 
streptococci, especially type 12 strains, produced bacteri-
ocines much more consistently and to a much greater extent 
than non-nephritogenic strains. Her results were subsequent-
ly disputed by Overtuf and Mortimer (85), and by Noble and 
Vosti (83), who found no major differences in bacteriocine 
production among strains of group A streptococci. 
Thus we are still left with two major "antigen" theo-
ries - either an immune-complex mechanism or a cross-reacting 
phenomenon. It would seem unlikely that only certain group 
A streptococcal types would have antigens with the ability 
to form soluble immune complexes, or antigens with a propen-
sity for binding in the renal glomerulus. It would also seem 
unlikely that only the group A. streptococci, out of all of 
the organisms in the bacterial kingdom, would have these 
109 
characteristics. Undoubtedly some forms of the disease glom-
erulonephritis are immune-complex mediated. Whether post-
streptococcal glomerulonephritis is immune-complex mediated 
seems unlikely, in light of the fact that the disease has 
never been experimentally produced with complexes of strep-
tococcal antigens and anti-streptococcal antibodies. At the 
present time no conclusive evidence exists which identifies 
the nature of a streptococcal antigen which forms pathogenic 
immune-complexes. If the immune-compl~x theory is correct, 
however, one would then have to conclude from the present 
work that many normal autopsy kidneys, from humans and es-
pecially neonatal mice, have streptococcal antigens bound, 
either free or as immune-complexes; in their glomeruli. 
Such a conclusion is presently untenable, due to the lack of 
experimental or clinical evidence. 
More logically, an antigenic cross-reaction, with evi-
dence here to support it, and by others (33,34,44,67,122), 
is more feasible. Immunology now recognizes the tremendous 
diversity and specificity of antigenic determinants. Out of 
such tremendous diversity it.is not unbelievable that two 
antigenic determinants would arise, in separate species of 
living organisms, which are similar or identical. Indeed, 
with group A streptococci alone, evidence is accumulating 
which indicates the existence of a large degree of antigenic 
mimicry between certain of the organisms and a wide variety 
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of tissues of several animals (52,59,62,63,95). Antigenic 
cross-reaction is not an uncommon phenomenon in nature. 
That it could lead to a disease state is the hypothesis sup-
ported here. 
If the cross-reactive theory is correct, one might 
wonder why more people do not develop the acute disease, 
since infection with group A streptococci, even nephritogenic 
strains, is very common. Even in epidemics of streptococcal 
diseases, with a single nephritogenic-~train, the incidence 
of subsequent renal involvement is low (36,86). One reason 
might be that all people do not possess the cross-reacting 
antigen on their GBM. Differential antigenic specificities 
among a population, which is genetically determined, is well 
recognized. In this study, in which only the positive re-
sults with human kidney sections were reported, it was noted 
that not all of the kidneys tested reacted positively with 
anti-SCM antisera, even after CHOase treatment. An expanded 
survey of the reaction of anti-SCM antisera with many human 
kidneys seems warranted. Rapaport et al. (93,94) found a 
similar differential reactivity is an outbred population of 
guinea pigs, which were sensitive to accelerated skin graft 
rejection after pretreatment with antiserum to group A type 
12 streptococcal cell membrane. In their studies, not all 
guinea pigs responded, by graft rejection, after inoculation 
with SCM antisera. It was theorized that only some of the 
--
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guinea pigs contained the tissue antigens.which cross-reacted 
with SCM, and that the antigen was randomly distributed 
throughout the population. The same random distribution of 
cross-reacting antigens may hold for GBM antigens in glomeru-
lonephri tis. 
A second factor in development of the disease, if due 
to a cross-reaction, would be the ability to respond, or the 
intensity of the antibody response, to the cross-reacting 
SCM antigen by the individual. If no~esponse was made, or 
if the response was minimal, disease symptoms would not re-
sult. 
A third factor might be the degree of masking of cross-
reacti ve antigenic sites by carbohydrate on the GBM. Heavy 
masking may prevent enough antibody attachment to produce 
significant damage. This may in part be related to the fact 
that streptococcal-related glomerulonephritis is a disease 
chiefly of children. The results of the present study show, 
although neonatal kidneys were used, that there is less mask-
ing of cross-reactive sites at an earlier age. Increased 
carbohydrate binding with age may have a protective effect. 
However, the development of the disease would seem to war-
rant an unmasking of carbohydrate-protected antigenic sites. 
This could be accomplished by macrophages or polymorphonu-
clear leukocytes, originally drawn to the site by antibody 
attachment to unmasked sites, and their subsequent release 
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of carbohydrate-cleaving enzymes, leading to further anti-
body deposition and damage. 
Post-streptococcal glomerulonephritis is a disease 
which usually results in recovery, rather than a procession 
to chronicity and death, as with other forms of the disease. 
Recovery could be the result of two related mechanisms. A 
clearance of SCM antigens which elicit cross-reacting anti-
bodies might eventually occur, along with a gradual decline 
in the production of anti-SCM antibodi:-es. Without the SCM 
antibodies, the damaged GBM might then be repaired. Repair 
of GBM could be carried out by synthesis of new GBM, and 
evidence has been reported that in both humans and rats there 
is a continuous turnover and replacement of glomerular base-
ment membrane (56,117,118). 
Thus the sequence of events in post-streptococcal 
glomerulonephritis could proceed as follows: Following an 
initial infection, either pharyngitic or pyodermal, the im-
mune response would include antibodies with a specificity 
for a GBM antigen. Circulation of antibodies through the 
kidney glomerulus would result in attachment to unmasked 
cross-reactive sites, with subsequent complement activation. 
Macrophages, and polymorphonuclear leukocytes, drawn to the 
site could produce further damage and also unmask more cross-
reactive determinants by the release of carbohydrases. Evi-
dence has been presented (126) which shows that lymphocytes 
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also become sensitized to SCM antigens, which could result 
in cellular cross-reactivity, and additional GBM damage. Un-
masked sites now free to react with more antibodies would do 
so, and the additive effect of immune reactions would lead 
to the symptoms of glomerulonephritis. Subsequent diminu-
tion of cross-reacting antibodies would lead to recovery, 
along with repair of the GBM by turnover and re-synthesis. 
In those cases which do become chronic the patient may be-
come antigenically sensitized to his O\'ffi GBM, due to its re-
lease into the circulation after damage by the cross-react-
ing immune response. If this is the case the patient may 
now have developed true auto-immune glomerulonephritis. 
It is realized that the studies presented here do not 
prove or disprove any theory of the pathogenesis of post-
streptococcal glomerulonephritis. It is hoped, however, 
that they have added to the understanding of a possible 
mechanism for the development of a serious disease. 
CHAPTER V 
SUlVIlV'.ARY 
Antigenic cross-reactivity between human and mouse 
glomerular basement membrane.(GBM) and group A, type 12 
streptococcal cell membrane (SCM) was evaluated employing 
several immunological techniques. Reciprocal cross-reactiv-
ity was found between human GBM and SCM, using several anti-
sera against each, by in vitro indirec~ immunofluorescence, 
antiserum absorption and immunodiffusion tests. Cross-re-
active antigenic sites on adult human and mouse GBM appeared 
to be masked by carbohydrate units, as revealed by the use 
of carbohydrate cleaving enzymes in in vitro fluorescent an-
tibody tests. Neonatal GBM's were more reactive, with both 
anti-GBM and anti-SCM antisera, in both in vitro and in vivo 
mouse tests, and thus appeared to be unmasked, or less marked, 
than adult GBM's. Carbohydrase treatment had little or no 
effect on neonatal GBM's. Chemical analyses, for carbohy-
drate and amino acid contents supported the masking hypothe-
sis, since neonatal GBM's were found to contain less total 
carbohydrate than adult GBM's, and less hydroxylysine. The 
results were discussed as supportive evidence for a cross-
reactive hypothesis in the pathogenesis of post-streptococcal 
glomerulonephritis. 
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